CMPD_CHEMBLID	MOLREGNO	PARENT_CMPD_CHEMBLID	PARENT_MOLREGNO	MOL_PREF_NAME	COMPOUND_KEY	MOLWEIGHT	ALOGP	PSA	NUM_RO5_VIOLATIONS	CANONICAL_SMILES	ACTIVITY_ID	STANDARD_TYPE	RELATION	STANDARD_VALUE	STANDARD_UNITS	PCHEMBL_VALUE	PUBLISHED_TYPE	PUBLISHED_RELATION	PUBLISHED_VALUE	PUBLISHED_UNITS	ACTIVITY_COMMENT	DATA_VALIDITY_COMMENT	POTENTIAL_DUPLICATE	BAO_ENDPOINT	UO_UNITS	QUDT_UNITS	ASSAY_ID	ASSAY_CHEMBLID	ASSAY_TYPE	DESCRIPTION	ASSAY_SRC_ID	ASSAY_SRC_DESCRIPTION	ASSAY_ORGANISM	ASSAY_STRAIN	ASSAY_TAX_ID	CURATED_BY	BAO_FORMAT	TID	TARGET_CHEMBLID	TARGET_TYPE	PROTEIN_ACCESSION	PREF_NAME	ORGANISM	CONFIDENCE_SCORE	TARGET_MAPPING	APD_NAME	APD_CONFIDENCE	DOC_ID	DOC_CHEMBLID	PUBMED_ID	JOURNAL	YEAR	VOLUME	ISSUE	FIRST_PAGE	CELL_ID	CELL_CHEMBL_ID	CELL_NAME	ACTIVITY_PARAMS	ACTIVITY_PROPS
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3418806	FC	=	.992	-		FC	=	.992				0				653361	CHEMBL1226564	F	Antiproliferative activity against human PC3 cells at 250 nM after 120 hrs by MTT assay relative to DMSO	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	80390	CHEMBL390	CELL-LINE		PC-3	Homo sapiens	1	Non-molecular			52308	CHEMBL1221184	16680159	Nat. Chem. Biol.	2006	2	6	329	555	CHEMBL3307570	PC-3		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	10947447	MBC	=	256	ug ml-1		MBC	=	256	ug ml-1			0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	827367	CHEMBL2051037	F	Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 by microbroth dilution method	1	Scientific Literature	Mycobacterium tuberculosis H37Ra	ATCC 25177	419947	Autocuration	BAO_0000218	106765	CHEMBL2366634	ORGANISM		Mycobacterium tuberculosis H37Ra	Mycobacterium tuberculosis H37Ra	1	Non-molecular			62474	CHEMBL2046301	22633120	Bioorg. Med. Chem.	2012	20	13	4149					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	677871	T/C	=	.9	-		T/C	=	.9				0				117257	CHEMBL723563	F	Compound (0.4 mmol/Kg) was evaluated for its ability to inhibit B16BL6 pulmonary metastasis in mice. The number of lung metastases of treated (T) and nontreated or control (C) is expressed as ratio, T/C.	1	Scientific Literature	Mus musculus		10090	Intermediate	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			15051	CHEMBL1132333	10447943	J. Med. Chem.	1999	42	16	3014					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	16469726	IC50	=	18600	nM	4.73	IC50	=	18.6	uM			0	BAO_0000190	UO_0000065	http://www.openphacts.org/units/Nanomolar	1555517	CHEMBL3768099	B	Inhibition of MANT-uracil binding to Caenorhabditis elegans CRBN (delta 1 to 15) by FRET assay	1	Scientific Literature	Caenorhabditis elegans		6239	Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			98322	CHEMBL3763149	26730808	J. Med. Chem.	2016	59	2	770					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3233231	IC50	>	50000	nM		IC50	>	50	uM			0	BAO_0000190	UO_0000065	http://www.openphacts.org/units/Nanomolar	622763	CHEMBL1107702	F	Cytotoxicity against human DLD1 cells by MTT assay	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	80120	CHEMBL614285	CELL-LINE		DLD-1	Homo sapiens	1	Non-molecular			49997	CHEMBL1153763	19394719	Eur. J. Med. Chem.	2009	44	9	3533	565	CHEMBL3307580	DLD-1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3106413	Activity	=	7	%		Activity	=	7	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	610471	CHEMBL1064325	F	Induction of apoptosis in human Jurkat T cells at 10 uM after 24 hrs by flow cytometry	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	81072	CHEMBL397	CELL-LINE		Jurkat	Homo sapiens	1	Non-molecular			49883	CHEMBL1159046	20034801	Bioorg. Med. Chem.	2010	18	2	650	503	CHEMBL3307526	Jurkat		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2474395	Activity	=	66	%		Activity	=	66	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	536005	CHEMBL988021	F	Induction of apoptosis in mouse Ehrlich ascites carcinoma cells implanted in Swiss albino mouse assessed as increase in Fas-L expression treated after 7 days post-tumor implantation at 1.25 mM/kg, sc for 5 days by immunohistochemical analysis	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000218	80830	CHEMBL614641	CELL-LINE		Ehrlich	Mus musculus	1	Non-molecular			44747	CHEMBL1151683	18951804	Bioorg. Med. Chem.	2008	16	22	9708	666	CHEMBL3307669	Ehrlich		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2474401	Activity	=	66	%		Activity	=	66	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	536020	CHEMBL990701	F	Antiangiogenic activity against mouse Ehrlich ascites carcinoma cells implanted in Swiss albino mouse assessed as inhibition of VEGF expression treated after 7 days post-tumor implantation at 1.25 mM/kg, sc for 5 days by immunohistochemical analysis	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000218	80830	CHEMBL614641	CELL-LINE		Ehrlich	Mus musculus	1	Non-molecular			44747	CHEMBL1151683	18951804	Bioorg. Med. Chem.	2008	16	22	9708	666	CHEMBL3307669	Ehrlich		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2373841	Activity	=	55.5	%		Activity	=	55.5	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	535236	CHEMBL981695	F	Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha synthesis at 10 uM pretreated for 3 hrs before LPS challenge assessed after 24 hrs by ELISA relative to control	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000219	80418	CHEMBL612557	CELL-LINE		RAW264.7	Mus musculus	1	Non-molecular			44554	CHEMBL1144167	18723357	Bioorg. Med. Chem.	2008	16	18	8619	343	CHEMBL3307977	RAW264.7		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	1987703	Inhibition	=	38	%		Inhibition	=	38	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	449733	CHEMBL898839	F	Inhibition of TNF gene expression in FRT Jurkat TNF reporter cells at 100 uM	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	81072	CHEMBL397	CELL-LINE		Jurkat	Homo sapiens	1	Non-molecular			37036	CHEMBL1137495	17851074	Bioorg. Med. Chem. Lett.	2007	17	21	5819	503	CHEMBL3307526	Jurkat		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Tha	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	12413941	Inhibition	=	28.2	%		INH	=	28.2	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	901293	CHEMBL3047051	B	Inhibition of iNOS in Mus musculus (mouse) RAW 264.7 cells assessed as inhibition of LPS-induced nitrite production pretreated for 24 hr before stimulation with LPS measured after 18 hr by ELISA	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000019	11039	CHEMBL3464	SINGLE PROTEIN	P29477	Nitric oxide synthase, inducible	Mus musculus	9	Protein			69013	CHEMBL3045031		Med Chem Res	2012	21	7	953					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1 (Thalidomide)	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	612744	Inhibition	~	80	%		Inhibition	~	80	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	212406	CHEMBL816158	F	Inhibition of TNF-alpha production from human monocytes upon stimulation with bacterial lipopolysaccharide (LPS) at a concentration of 100 uM	1	Scientific Literature				Autocuration	BAO_0000019	185	CHEMBL1825	SINGLE PROTEIN	P01375	TNF-alpha	Homo sapiens	8	Homologous protein			13492	CHEMBL1129257	8759624	J. Med. Chem.	1996	39	16	3044					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7834126	HepSE_cirrhosis	=	0	-		HepSE_cirrhosis	=	0				0				774788	CHEMBL1909310	A	Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis	1	Scientific Literature				Autocuration	BAO_0000221	103956	CHEMBL1697861	PHENOTYPE		Hepatotoxicity		1	Non-molecular			59327	CHEMBL1909294	22194678	PLOS Computational Biology	2011	7	12	1					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7834133	HepSE_liver disease	=	0	-		HepSE_liver disease	=	0				0				774795	CHEMBL1909317	A	Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease	1	Scientific Literature				Autocuration	BAO_0000221	103956	CHEMBL1697861	PHENOTYPE		Hepatotoxicity		1	Non-molecular			59327	CHEMBL1909294	22194678	PLOS Computational Biology	2011	7	12	1					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7834125	HepSE_cholelithiasis	=	0	-		HepSE_cholelithiasis	=	0				0				774787	CHEMBL1909309	A	Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis	1	Scientific Literature				Autocuration	BAO_0000221	103956	CHEMBL1697861	PHENOTYPE		Hepatotoxicity		1	Non-molecular			59327	CHEMBL1909294	22194678	PLOS Computational Biology	2011	7	12	1					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7834129	HepSE_hepatic necrosis	=	0	-		HepSE_hepatic necrosis	=	0				0				774791	CHEMBL1909313	A	Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis	1	Scientific Literature				Autocuration	BAO_0000221	103956	CHEMBL1697861	PHENOTYPE		Hepatotoxicity		1	Non-molecular			59327	CHEMBL1909294	22194678	PLOS Computational Biology	2011	7	12	1					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7834127	HepSE_elevated liver function tests	=	0	-		HepSE_elevated liver function tests	=	0				0				774789	CHEMBL1909311	A	Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests	1	Scientific Literature				Autocuration	BAO_0000221	103956	CHEMBL1697861	PHENOTYPE		Hepatotoxicity		1	Non-molecular			59327	CHEMBL1909294	22194678	PLOS Computational Biology	2011	7	12	1					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thl	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13460565	Activity					Activity				Active		0	BAO_0000375			984967	CHEMBL2433016	F	Immunomodulatory activity in carrageenan-induced air pouch mouse model assessed as reduction of nitric oxide production in air pouch at 10 mg/kg, po by Griess method	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			74939	CHEMBL2429842		Med Chem Res	2013			1					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	9340029	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809099	CHEMBL1964085	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the M14 Melanoma cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80214	CHEMBL614317	CELL-LINE		M14	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							577	CHEMBL3307591	M14		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	10041373	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809330	CHEMBL1963882	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MCF7 Breast cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80224	CHEMBL387	CELL-LINE		MCF7	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							491	CHEMBL3308403	MCF7		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8946310	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809063	CHEMBL1964049	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-5 Ovarian cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80356	CHEMBL614214	CELL-LINE		OVCAR-5	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							548	CHEMBL3307565	OVCAR-5		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	10273363	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809369	CHEMBL1963921	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-MB-435 Breast cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	81245	CHEMBL614697	CELL-LINE		MDA-MB-435	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							687	CHEMBL3307686	MDA-MB-435		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID11532929	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	11662830	Potency		562.3	nM		Potency		.5623	uM	inactive		0	BAO_0000186	UO_0000065	http://www.openphacts.org/units/Nanomolar	845169	CHEMBL2114780	F	PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) 	7	PubChem BioAssays	Homo sapiens		9606	Autocuration	BAO_0000219	103711	CHEMBL1293278	SINGLE PROTEIN	O75496	Geminin	Homo sapiens	9	Protein			51887	CHEMBL1201862							773	CHEMBL3307758	SW480		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID11532929	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7308441	Potency		1651.1	nM		Potency		1.6511	uM	inactive		0	BAO_0000186	UO_0000065	http://www.openphacts.org/units/Nanomolar	752590	CHEMBL1794580	F	PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850]	7	PubChem BioAssays	Plasmodium falciparum		5833	Autocuration	BAO_0000218	50425	CHEMBL364	ORGANISM		Plasmodium falciparum	Plasmodium falciparum	1	Non-molecular			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID174007312	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	14342380	Potency		3755.3	nM		Potency		3.7553	uM	inactive		0	BAO_0000186	UO_0000065	http://www.openphacts.org/units/Nanomolar	1301766	CHEMBL3214813	F	PubChem BioAssay. qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation (Rep 2).   (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000019	22221	CHEMBL3879801	NON-MOLECULAR		Placeholder for assays where the target is a tissue/organism etc		1	Non-molecular			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID90341724	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	5751402	Potency		33587.5	nM		Potency		33.5875	uM	inactive		0	BAO_0000186	UO_0000065	http://www.openphacts.org/units/Nanomolar	737344	CHEMBL1738442	F	PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404]	7	PubChem BioAssays	Homo sapiens		9606	Autocuration	BAO_0000019	102672	CHEMBL6032	SINGLE PROTEIN	Q96KQ7	Histone-lysine N-methyltransferase, H3 lysine-9 specific 3	Homo sapiens	9	Protein			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	4	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2459414	Activity					Activity				Not Active		0	BAO_0000375			488145	CHEMBL987436	F	Antagonist activity at progesterone receptor in human T47D cells assessed as inhibition of progesterone-induced alkaline phosphatase activity at 100 uM	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	36	CHEMBL208	SINGLE PROTEIN	P06401	Progesterone receptor	Homo sapiens	9	Protein			43849	CHEMBL1155106	18586498	Bioorg. Med. Chem.	2008	16	14	7046	594	CHEMBL3307606	T47D		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	(+/-)-Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3491186	Inhibition					INH				Not Active		0	BAO_0000376			669088	CHEMBL1266185	F	Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			53172	CHEMBL1255231	17417631	Nat. Chem. Biol.	2007	3	5	268					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	5318841	Hepatotoxicity					Hepatotoxicity				drug-induced liver injury reported		0				736785	CHEMBL1697779	A	Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents	1	Scientific Literature	Rodentia		9989	Autocuration	BAO_0000221	103956	CHEMBL1697861	PHENOTYPE		Hepatotoxicity		1	Non-molecular			56111	CHEMBL1697731	20014752	Chem. Res. Toxicol.	2010	23	1	171					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346643	CK	=	138	U.L-1		CREATINE PHOSPHOKINASE	=	138	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CK (Creatine Kinase) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346637	ALB	=	34700	ug.mL-1		ALBUMIN	=	3.47	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = ALB (Albumin) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345767	AST	=	66.67	U.L-1		ASPARTATE AMINOTRANSFERASE	=	66.67	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = AST (Aspartate Aminotransferase) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346710	HCT	=	45.37	%		HEMATOCRIT	=	45.37	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HCT (Hematocrit) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346682	HCT	=	45.93	%		HEMATOCRIT	=	45.93	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HCT (Hematocrit) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346681	RBC	=	7360000	cells.uL-1		ERYTHROCYTE COUNT	=	7.36	x10E6/uL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = RBC (Erythrocytes) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346614	CHOL	=	576.7	ug.mL-1		CHOLESTEROL	=	57.67	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CHOL (Cholesterol) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346698	CHOL	=	773.3	ug.mL-1		CHOLESTEROL	=	77.33	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CHOL (Cholesterol) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345809	GLUC	=	1968.3	ug.mL-1		GLUCOSE	=	196.83	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = GLUC (Glucose) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346674	PHOS	=	120.3	ug.mL-1		PHOSPHORUS	=	12.03	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PHOS (Phosphate) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345935	PLAT	=	1298000	cells.uL-1		PLATELET COUNT	=	1298	x10E3/uL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PLAT (Platelets) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346644	CREAT	=	5	ug.mL-1		CREATININE	=	.5	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CREAT (Creatinine) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345851	BASOLE	=	1.35	%		BASOPHIL	=	1.35	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BASOLE (Basophils/Leukocytes) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345655	BASOLE	=	1.52	%		BASOPHIL	=	1.52	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BASOLE (Basophils/Leukocytes) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345725	MONOLE	=	2.13	%		MONOCYTE	=	2.13	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MONOLE (Monocytes/Leukocytes) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346717	MONOLE	=	2.73	%		MONOCYTE	=	2.73	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MONOLE (Monocytes/Leukocytes) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346662	NEUTLE	=	13.67	%		NEUTROPHIL	=	13.67	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = NEUTLE (Neutrophils/Leukocytes) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345634	SODIUM	=	148	mEq.L-1		SODIUM	=	148	MEQ/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = SODIUM (Sodium) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346620	SODIUM	=	148.67	mEq.L-1		SODIUM	=	148.67	MEQ/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = SODIUM (Sodium) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483284	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, CENTRILOBULAR, ATROPHY | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483286	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, CENTRILOBULAR, DEGENERATION | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483288	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, CENTRILOBULAR, HYPERTROPHY | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483297	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, MIDZONAL, NECROSIS, APOPTOTIC | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483304	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, NONZONAL, LIPID ACCUMULATION, MICROVESICULAR | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483312	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, PERIPORTAL, LIPID ACCUMULATION, MACROVESICULAR | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483315	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, PERIPORTAL, NECROSIS, ONCOCYTIC | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483328	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PERIPORTAL, INFLAMMATORY CELL INFILTRATE, NEUTROPHILIC | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801906	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774763	CHEMBL1909152	B	DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801898	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774759	CHEMBL1909148	B	DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801978	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774667	CHEMBL1909188	B	DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF)	15	DrugMatrix			32644	Autocuration	BAO_0000219	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046							723	CHEMBL3307716	NIH3T3		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804081	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774717	CHEMBL1909106	B	DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630)	15	DrugMatrix			32644	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804099	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774726	CHEMBL1909115	B	DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone)	15	DrugMatrix	Escherichia coli		562	Autocuration	BAO_0000249	12832	CHEMBL3072	SINGLE PROTEIN	P15207	Androgen Receptor	Rattus norvegicus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801918	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774769	CHEMBL1909158	B	DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA)	15	DrugMatrix	Escherichia coli		562	Autocuration	BAO_0000357	24	CHEMBL402	SINGLE PROTEIN	P04035	HMG-CoA reductase	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801966	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774661	CHEMBL1909182	B	DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	129	CHEMBL233	SINGLE PROTEIN	P35372	Mu opioid receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801974	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774665	CHEMBL1909186	B	DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP)	15	DrugMatrix	Homo sapiens		9606	Autocuration	BAO_0000221	3	CHEMBL1827	SINGLE PROTEIN	O76074	Phosphodiesterase 5A	Homo sapiens	9	Protein			59306	CHEMBL1909046							5578	CHEMBL3833781	Platelet		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799782	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774702	CHEMBL1909091	B	DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)	15	DrugMatrix			32644	Autocuration	BAO_0000249	50	CHEMBL213	SINGLE PROTEIN	P08588	Beta-1 adrenergic receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799786	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774704	CHEMBL1909093	B	DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol)	15	DrugMatrix			32644	Autocuration	BAO_0000249	226	CHEMBL246	SINGLE PROTEIN	P13945	Beta-3 adrenergic receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801994	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774675	CHEMBL1909196	B	DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)	15	DrugMatrix	Homo sapiens		9606	Autocuration	BAO_0000221	13000	CHEMBL332	SINGLE PROTEIN	P03956	Matrix metalloproteinase-1	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802010	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774683	CHEMBL1909204	B	DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))	15	DrugMatrix			32644	Autocuration	BAO_0000219	11755	CHEMBL1841	SINGLE PROTEIN	P06241	Tyrosine-protein kinase FYN	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799772	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774697	CHEMBL1909086	B	DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	12474	CHEMBL315	SINGLE PROTEIN	P15823	Alpha-1b adrenergic receptor	Rattus norvegicus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802006	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774681	CHEMBL1909202	B	DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)	15	DrugMatrix	Escherichia coli		562	Autocuration	BAO_0000357	12579	CHEMBL4445	SINGLE PROTEIN	Q08209	Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801967	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774662	CHEMBL1909183	B	DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu)	15	DrugMatrix	Mus musculus	ICR	10090	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801899	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774760	CHEMBL1909149	B	DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799833	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774745	CHEMBL1909134	B	DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)	15	DrugMatrix			32644	Autocuration	BAO_0000219	12912	CHEMBL3622	SINGLE PROTEIN	P33261	Cytochrome P450 2C19	Homo sapiens	9	Protein			59306	CHEMBL1909046							5579	CHEMBL3833782	BTI-TN-5B1-4		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801963	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774660	CHEMBL1909181	B	DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	137	CHEMBL237	SINGLE PROTEIN	P41145	Kappa opioid receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804086	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774720	CHEMBL1909109	B	DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	121	CHEMBL228	SINGLE PROTEIN	P31645	Serotonin transporter	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799855	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774756	CHEMBL1909145	B	DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol)	15	DrugMatrix			32644	Autocuration	BAO_0000219	19	CHEMBL206	SINGLE PROTEIN	P03372	Estrogen receptor alpha	Homo sapiens	9	Protein			59306	CHEMBL1909046							1759	CHEMBL3308860	Sf9		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799819	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774738	CHEMBL1909127	B	DRUGMATRIX: Chemokine CXCR1 (IL-8A)	15	DrugMatrix			32644	Autocuration	BAO_0000357	11574	CHEMBL4029	SINGLE PROTEIN	P25024	Interleukin-8 receptor A	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799821	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774739	CHEMBL1909128	B	DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10773	CHEMBL2434	SINGLE PROTEIN	P25025	Interleukin-8 receptor B	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799787	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774705	CHEMBL1909094	B	DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55)	15	DrugMatrix			32644	Autocuration	BAO_0000249	100	CHEMBL222	SINGLE PROTEIN	P23975	Norepinephrine transporter	Homo sapiens	9	Protein			59306	CHEMBL1909046							499	CHEMBL3308370	MDCK		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801957	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774657	CHEMBL1909178	B	DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)	15	DrugMatrix	Rattus norvegicus		10116	Autocuration	BAO_0000221	11677	CHEMBL3048	SINGLE PROTEIN	P29476	Nitric-oxide synthase, brain	Rattus norvegicus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802023	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774690	CHEMBL1909211	B	DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin)	15	DrugMatrix			32644	Autocuration	BAO_0000249	107	CHEMBL224	SINGLE PROTEIN	P28223	Serotonin 2a (5-HT2a) receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802025	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774715	CHEMBL1909104	B	DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide)	15	DrugMatrix			32644	Autocuration	BAO_0000249	227	CHEMBL1833	SINGLE PROTEIN	P41595	Serotonin 2b (5-HT2b) receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799791	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774707	CHEMBL1909096	B	DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)	15	DrugMatrix			32644	Autocuration	BAO_0000219	10692	CHEMBL4607	SINGLE PROTEIN	P50052	Angiotensin II type 2 (AT-2) receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802005	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774681	CHEMBL1909202	B	DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)	15	DrugMatrix	Escherichia coli		562	Autocuration	BAO_0000357	12579	CHEMBL4445	SINGLE PROTEIN	Q08209	Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7850865	GI	=	40	%		GI	=	40	%			0	BAO_0000096	UO_0000187	http://qudt.org/vocab/unit#Percent	775472	CHEMBL1913047	A	Antiproliferative activity against human ECV304 cells assessed as growth inhibition after 72 hrs by MTT assay	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	80129	CHEMBL614035	CELL-LINE		ECV-304	Homo sapiens	1	Non-molecular			59428	CHEMBL1909561	21963304	Bioorg. Med. Chem. Lett.	2011	21	21	6242	487	CHEMBL3307513	ECV-304		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	5082298	T1/2	=	4.7	hr		t1/2	=	4.7	h			0	BAO_0002115	UO_0000032	http://qudt.org/vocab/unit#Hour	688906	CHEMBL1614674	A	Half life in human after iv administration	1	Scientific Literature	Homo sapiens		9606	Expert	BAO_0000218	22224	CHEMBL612558	ADMET		ADMET		0	Unassigned			54149	CHEMBL1614632	18426954	Drug Metab. Dispos.	2008	36	7	1385					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thl	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15620244	Activity	=	2	%		Activity	=	2	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	1498239	CHEMBL3583662	A	Induction of total cell death in human Jurkat cells containing GFP gene under control of TNF gene promoter at 10 uM incubated for 24 hrs by propidium iodide staining based assay	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	81072	CHEMBL397	CELL-LINE		Jurkat	Homo sapiens	1	Non-molecular			92436	CHEMBL3580609		MedChemComm	2014	5	6	758	503	CHEMBL3307526	Jurkat		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7850881	Activity	=	53	%		Activity	=	53	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	775473	CHEMBL1913048	A	Antiproliferative activity against human HUVEC assessed as tube formation at 195 uM after 24 hrs	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	81057	CHEMBL613979	CELL-LINE		HUVEC	Homo sapiens	1	Non-molecular			59428	CHEMBL1909561	21963304	Bioorg. Med. Chem. Lett.	2011	21	21	6242	473	CHEMBL3307501	HUVEC		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	(+/-)-1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2673363	Activity	=	86.5	%		Activity	=	86.5	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	575154	CHEMBL1035533	F	Cytotoxicity against human MCF7 cells assessed as cell viability at 100 ug/ml after 72 hrs by MTT assay	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	80224	CHEMBL387	CELL-LINE		MCF7	Homo sapiens	1	Non-molecular			47527	CHEMBL1151853	19297157	Bioorg. Med. Chem. Lett.	2009	19	14	3973	491	CHEMBL3308403	MCF7		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thl	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15620227	Inhibition	=	5	%		INH	=	5	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	1498235	CHEMBL3583658	F	Inhibition of TNFalpha expression in human Jurkat cells containing GFP gene under control of TNF gene promoter at 10 uM incubated for 24 hrs	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	81072	CHEMBL397	CELL-LINE		Jurkat	Homo sapiens	1	Non-molecular			92436	CHEMBL3580609		MedChemComm	2014	5	6	758	503	CHEMBL3307526	Jurkat		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	1660515	Inhibition	=	26	%		Inhibition	=	26	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	326959	CHEMBL853295	F	Inhibitory activity in HUVEC tube formation assay at 100 uM	1	Scientific Literature	Homo sapiens		9606	Intermediate	BAO_0000219	81057	CHEMBL613979	CELL-LINE		HUVEC	Homo sapiens	1	Non-molecular			30429	CHEMBL1141962	16183272	Bioorg. Med. Chem. Lett.	2005	15	24	5509	473	CHEMBL3307501	HUVEC		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13801376	Inhibition	=	101.03	%		Inhibition	=	101.0346933	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	1265865	CHEMBL3039491	A	Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM	1	Scientific Literature	Cricetulus griseus		10029	Autocuration	BAO_0000219	104062	CHEMBL1743121	SINGLE PROTEIN	Q9NPD5	Solute carrier organic anion transporter family member 1B3	Homo sapiens	8	Homologous protein			75466	CHEMBL3039007	23571415	Mol. Pharmacol.	2013	83	6	1257	449	CHEMBL3308072	CHO		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7834130	HepSE_hepatitis	=	1	-		HepSE_hepatitis	=	1				0				774792	CHEMBL1909314	A	Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis	1	Scientific Literature				Autocuration	BAO_0000221	103956	CHEMBL1697861	PHENOTYPE		Hepatotoxicity		1	Non-molecular			59327	CHEMBL1909294	22194678	PLOS Computational Biology	2011	7	12	1					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1 (Thal)	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	1481500	Cell proliferation	=	101	%		Cell proliferation	=	101	%			0		UO_0000187	http://qudt.org/vocab/unit#Percent	317077	CHEMBL825407	F	Percent cell proliferation of human leukemia cell line HL-60 at 1*E-5 M	1	Scientific Literature	Homo sapiens		9606	Intermediate	BAO_0000219	80156	CHEMBL383	CELL-LINE		HL-60	Homo sapiens	1	Non-molecular			20525	CHEMBL1139643	15936192	Bioorg. Med. Chem. Lett.	2005	15	13	3212	649	CHEMBL3307654	HL-60		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7834131	HepSE_hepatomegaly	=	1	-		HepSE_hepatomegaly	=	1				0				774793	CHEMBL1909315	A	Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly	1	Scientific Literature				Autocuration	BAO_0000221	103956	CHEMBL1697861	PHENOTYPE		Hepatotoxicity		1	Non-molecular			59327	CHEMBL1909294	22194678	PLOS Computational Biology	2011	7	12	1					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2373847	Activity					Activity				Active		0	BAO_0000375			535241	CHEMBL981700	F	Reduction in pERK1/2 expression in LPS-activated mouse RAW264.7 cells at 10 uM pretreated for 3 hrs before LPS challenge assessed after 24 hrs by Western blot	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000219	80418	CHEMBL612557	CELL-LINE		RAW264.7	Mus musculus	1	Non-molecular			44554	CHEMBL1144167	18723357	Bioorg. Med. Chem.	2008	16	18	8619	343	CHEMBL3307977	RAW264.7		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2373845	Activity					Activity				Active		0	BAO_0000375			535238	CHEMBL981697	F	Antiinflammatory activity in mouse LPS-activated RAW264.7 cells assessed as ROS scavenging activity at 10 uM pretreated for 3 hrs before LPS challenge measured by decrease in fluorescent intensity by confocal microscopy	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000219	80418	CHEMBL612557	CELL-LINE		RAW264.7	Mus musculus	1	Non-molecular			44554	CHEMBL1144167	18723357	Bioorg. Med. Chem.	2008	16	18	8619	343	CHEMBL3307977	RAW264.7		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	9704584	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809302	CHEMBL1963854	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the A549/ATCC Non-Small Cell Lung cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80682	CHEMBL392	CELL-LINE		A549	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							646	CHEMBL3307651	A549		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8425673	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809022	CHEMBL1963989	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80025	CHEMBL614519	CELL-LINE		ACHN	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							626	CHEMBL3307633	ACHN		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	9276069	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809091	CHEMBL1964077	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the KM12 Colon cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80192	CHEMBL614709	CELL-LINE		KM12	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							690	CHEMBL3307689	KM12		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	9951102	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809322	CHEMBL1963874	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-116 Colon cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80928	CHEMBL394	CELL-LINE		HCT-116	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							721	CHEMBL3308372	HCT-116		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	9790332	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809308	CHEMBL1963860	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCC-2998 Colon cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80920	CHEMBL613855	CELL-LINE		HCC 2998	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							451	CHEMBL3308074	HCC 2998		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8920496	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809059	CHEMBL1964045	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI/ADR-RES Breast cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80711	CHEMBL613829	CELL-LINE		NCI/ADR-RES	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							434	CHEMBL3308057	NCI/ADR-RES		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID90341724	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	14235417	Potency		30.1	nM		Potency		.0301	uM	inactive		0	BAO_0000186	UO_0000065	http://www.openphacts.org/units/Nanomolar	1301624	CHEMBL3215185	F	PubChem BioAssay. qHTS screen for enhancers of Arylsulfatase A (ASA1): LOPAC Validation Assay.   (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000019	10712	CHEMBL2193	SINGLE PROTEIN	P15289	Cerebroside-sulfatase	Homo sapiens	9	Protein			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	(+/-)-1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2673339	Activity					Activity				Not Active		0	BAO_0000375			575151	CHEMBL1035530	F	Antiangiogenic activity against VEGF-induced HUVEC assessed as tube joint at 100 uM after 11 days after 11 days by BCIP/NBT visualization assay	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	81057	CHEMBL613979	CELL-LINE		HUVEC	Homo sapiens	1	Non-molecular			47527	CHEMBL1151853	19297157	Bioorg. Med. Chem. Lett.	2009	19	14	3973	473	CHEMBL3307501	HUVEC		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15153674	Inhibition					INH				Not Active		0	BAO_0000376			1462565	CHEMBL3399182	B	Inhibition of BRD4 bromodomain-1 (unknown origin) at 100 uM by europium based LANCE TR-FRET assay	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000357	103454	CHEMBL1163125	SINGLE PROTEIN	O60885	Bromodomain-containing protein 4	Homo sapiens	9	Protein			91024	CHEMBL3396987	25678016	Bioorg. Med. Chem.	2015	23	5	953					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13981537	Hepatotoxicity (time to onset)					Hepatotoxicity (time to onset)				5 days - 7 months		0				1301392	CHEMBL3137739	T	Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000019	22221	CHEMBL3879801	NON-MOLECULAR		Placeholder for assays where the target is a tissue/organism etc		1	Non-molecular			77450	CHEMBL3137667	15646539	Gastroenterol Clin Biol	2004	28	8-9	720					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13981525	Hepatotoxicity (choleostasis)	=	0	-		Hepatotoxicity (choleostasis)	=	0		references out of a total of 5		0				1301380	CHEMBL3137727	T	Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000221	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			77450	CHEMBL3137667	15646539	Gastroenterol Clin Biol	2004	28	8-9	720					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13981532	Hepatotoxicity (malignant tumour)	=	0	-		Hepatotoxicity (malignant tumour)	=	0		references out of a total of 5		0				1301387	CHEMBL3137734	T	Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			77450	CHEMBL3137667	15646539	Gastroenterol Clin Biol	2004	28	8-9	720					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346693	ALB	=	36700	ug.mL-1		ALBUMIN	=	3.67	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = ALB (Albumin) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345760	ALP	=	419	U.L-1		ALKALINE PHOSPHATASE	=	419	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = ALP (Alkaline Phosphatase) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345683	HGB	=	136200	ug.mL-1		HEMOGLOBIN	=	13.62	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HGB (Hemoglobin) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345879	HGB	=	139800	ug.mL-1		HEMOGLOBIN	=	13.98	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HGB (Hemoglobin) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346630	MCH	=	19.47	pg		MEAN CORPUSCULAR HEMOGLOBIN	=	19.47	PG	See Activity_Supp For Individual Animal Data		0		UO_0000025		1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MCH (Ery. Mean Corpuscular Hemoglobin) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346658	MCH	=	19.63	pg		MEAN CORPUSCULAR HEMOGLOBIN	=	19.63	PG	See Activity_Supp For Individual Animal Data		0		UO_0000025		1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MCH (Ery. Mean Corpuscular Hemoglobin) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346712	WBC	=	11230	cells.uL-1		LEUKOCYTE COUNT	=	11.23	x10E3/uL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = WBC (Leukocytes) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346621	BILI	=	3.3	ug.mL-1		TOTAL BILIRUBIN	=	.33	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BILI (Bilirubin) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346670	CHOL	=	700	ug.mL-1		CHOLESTEROL	=	70	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CHOL (Cholesterol) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346702	PHOS	=	113.3	ug.mL-1		PHOSPHORUS	=	11.33	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PHOS (Phosphate) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346719	PLAT	=	1316000	cells.uL-1		PLATELET COUNT	=	1316	x10E3/uL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PLAT (Platelets) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346616	CREAT	=	5	ug.mL-1		CREATININE	=	.5	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CREAT (Creatinine) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346680	EOSLE	=	.47	%		EOSINOPHIL	=	.47	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = EOSLE (Eosinophils/Leukocytes) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345893	LYMLE	=	80.83	%		LYMPHOCYTE	=	80.83	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = LYMLE (Lymphocytes/Leukocytes) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346623	BASOLE	=	1.53	%		BASOPHIL	=	1.53	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BASOLE (Basophils/Leukocytes) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346690	NEUTLE	=	15.2	%		NEUTROPHIL	=	15.2	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = NEUTLE (Neutrophils/Leukocytes) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346641	CHLORIDE	=	102.67	mEq.L-1		CHLORIDE	=	102.67	MEQ/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CHLORIDE (Chloride) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345823	POTASSIUM	=	6.47	mEq.L-1		POTASSIUM	=	6.47	MEQ/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = POTASSIUM (Potassium) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483300	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, NONZONAL, ERYTHROPHAGOCYTOSIS | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483274	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BILE DUCT DILATATION | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483276	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BILE DUCT, NECROSIS, ONCOCYTIC | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483287	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, CENTRILOBULAR, GLYCOGEN ACCUMULATION | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483295	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, MIDZONAL, LIPID ACCUMULATION, MACROVESICULAR | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483322	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = NONZONAL, INFLAMMATORY CELL INFILTRATE, MIXED CELL | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483323	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = OVAL CELL, HYPERPLASIA | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801988	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774672	CHEMBL1909193	B	DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)	15	DrugMatrix	Escherichia coli		562	Autocuration	BAO_0000357	11624	CHEMBL4801	SINGLE PROTEIN	P29466	Caspase-1	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801926	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774773	CHEMBL1909162	B	DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)	15	DrugMatrix			32644	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046							379	CHEMBL3308006	U-937		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801900	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774760	CHEMBL1909149	B	DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799836	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774746	CHEMBL1909135	B	DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)	15	DrugMatrix			32644	Autocuration	BAO_0000219	12911	CHEMBL3397	SINGLE PROTEIN	P11712	Cytochrome P450 2C9	Homo sapiens	9	Protein			59306	CHEMBL1909046							5579	CHEMBL3833782	BTI-TN-5B1-4		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799840	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774748	CHEMBL1909137	B	DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)	15	DrugMatrix			32644	Autocuration	BAO_0000219	20056	CHEMBL5281	SINGLE PROTEIN	P05181	Cytochrome P450 2E1	Homo sapiens	9	Protein			59306	CHEMBL1909046							5579	CHEMBL3833782	BTI-TN-5B1-4		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801916	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774768	CHEMBL1909157	B	DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	102	CHEMBL1941	SINGLE PROTEIN	P25021	Histamine H2 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799858	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774757	CHEMBL1909146	B	DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol)	15	DrugMatrix			32644	Autocuration	BAO_0000219	174	CHEMBL242	SINGLE PROTEIN	Q92731	Estrogen receptor beta	Homo sapiens	9	Protein			59306	CHEMBL1909046							1759	CHEMBL3308860	Sf9		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801998	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774677	CHEMBL1909198	B	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	15	DrugMatrix			32644	Autocuration	BAO_0000219	11635	CHEMBL299	SINGLE PROTEIN	P17252	Protein kinase C alpha	Homo sapiens	9	Protein			59306	CHEMBL1909046							1759	CHEMBL3308860	Sf9		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799854	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774755	CHEMBL1909144	B	DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1)	15	DrugMatrix			32644	Autocuration	BAO_0000249	249	CHEMBL252	SINGLE PROTEIN	P25101	Endothelin receptor ET-A	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801932	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774644	CHEMBL1909165	B	DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid)	15	DrugMatrix	Oryctolagus cuniculus		9986	Autocuration	BAO_0000221	20075	CHEMBL4358	SINGLE PROTEIN	P12530	Arachidonate 15-lipoxygenase	Oryctolagus cuniculus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799816	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774736	CHEMBL1909125	B	DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10579	CHEMBL2414	SINGLE PROTEIN	P51679	C-C chemokine receptor type 4	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799818	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774737	CHEMBL1909126	B	DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10580	CHEMBL274	SINGLE PROTEIN	P51681	C-C chemokine receptor type 5	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801952	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774654	CHEMBL1909175	B	DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10475	CHEMBL4777	SINGLE PROTEIN	P25929	Neuropeptide Y receptor type 1	Homo sapiens	9	Protein			59306	CHEMBL1909046							531	CHEMBL3307551	SK-N-MC		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802022	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774689	CHEMBL1909210	B	DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	10577	CHEMBL3459	SINGLE PROTEIN	P28564	Serotonin 1b (5-HT1b) receptor	Rattus norvegicus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801976	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774666	CHEMBL1909187	B	DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF)	15	DrugMatrix	Homo sapiens		9606	Autocuration	BAO_0000221	251	CHEMBL250	SINGLE PROTEIN	P25105	Platelet activating factor receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							5578	CHEMBL3833781	Platelet		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801946	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774651	CHEMBL1909172	B	DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	219	CHEMBL245	SINGLE PROTEIN	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804105	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774729	CHEMBL1909118	B	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	15	DrugMatrix			32644	Autocuration	BAO_0000219	10979	CHEMBL1868	SINGLE PROTEIN	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	9	Protein			59306	CHEMBL1909046							473	CHEMBL3307501	HUVEC		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801925	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774773	CHEMBL1909162	B	DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)	15	DrugMatrix			32644	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046							379	CHEMBL3308006	U-937		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801919	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774770	CHEMBL1909159	B	DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801909	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774765	CHEMBL1909154	B	DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801955	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774656	CHEMBL1909177	B	DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046							652	CHEMBL3307656	IMR-32		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799795	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774709	CHEMBL1909098	B	DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat))	15	DrugMatrix	Cavia porcellus	Dunkin-Hartley	10141	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799807	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774732	CHEMBL1909121	B	DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801911	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774766	CHEMBL1909155	B	DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	109556	CHEMBL3392921	PROTEIN COMPLEX GROUP	P07727, P20781, P22771, P24524	Glycine receptor	Rattus norvegicus	5	Multiple proteins			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799829	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774743	CHEMBL1909132	B	DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)	15	DrugMatrix			32644	Autocuration	BAO_0000219	12594	CHEMBL3356	SINGLE PROTEIN	P05177	Cytochrome P450 1A2	Homo sapiens	9	Protein			59306	CHEMBL1909046							5579	CHEMBL3833782	BTI-TN-5B1-4		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799835	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774746	CHEMBL1909135	B	DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)	15	DrugMatrix			32644	Autocuration	BAO_0000219	12911	CHEMBL3397	SINGLE PROTEIN	P11712	Cytochrome P450 2C9	Homo sapiens	9	Protein			59306	CHEMBL1909046							5579	CHEMBL3833782	BTI-TN-5B1-4		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799843	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774750	CHEMBL1909139	B	DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390)	15	DrugMatrix			32644	Autocuration	BAO_0000249	88	CHEMBL2056	SINGLE PROTEIN	P21728	Dopamine D1 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							449	CHEMBL3308072	CHO		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799851	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774754	CHEMBL1909143	B	DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55)	15	DrugMatrix			32644	Autocuration	BAO_0000249	155	CHEMBL238	SINGLE PROTEIN	Q01959	Dopamine transporter	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802003	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774680	CHEMBL1909201	B	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	15	DrugMatrix	Escherichia coli		562	Autocuration	BAO_0000357	10188	CHEMBL260	SINGLE PROTEIN	Q16539	MAP kinase p38 alpha	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801973	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774665	CHEMBL1909186	B	DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP)	15	DrugMatrix	Homo sapiens		9606	Autocuration	BAO_0000221	3	CHEMBL1827	SINGLE PROTEIN	O76074	Phosphodiesterase 5A	Homo sapiens	9	Protein			59306	CHEMBL1909046							5578	CHEMBL3833781	Platelet		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799763	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774693	CHEMBL1909214	B	DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA)	15	DrugMatrix			32644	Autocuration	BAO_0000249	252	CHEMBL251	SINGLE PROTEIN	P29274	Adenosine A2a receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801927	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774642	CHEMBL1909163	B	DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4)	15	DrugMatrix	Cavia porcellus		10141	Autocuration	BAO_0000221	104321	CHEMBL1909043	SINGLE PROTEIN	A6XA80	Leukotriene C4 synthase	Cavia porcellus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801937	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774647	CHEMBL1909168	B	DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH)	15	DrugMatrix			32644	Autocuration	BAO_0000249	11006	CHEMBL4608	SINGLE PROTEIN	P33032	Melanocortin receptor 5	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799853	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774755	CHEMBL1909144	B	DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1)	15	DrugMatrix			32644	Autocuration	BAO_0000249	249	CHEMBL252	SINGLE PROTEIN	P25101	Endothelin receptor ET-A	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799785	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774704	CHEMBL1909093	B	DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol)	15	DrugMatrix			32644	Autocuration	BAO_0000249	226	CHEMBL246	SINGLE PROTEIN	P13945	Beta-3 adrenergic receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801995	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774676	CHEMBL1909197	B	DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)	15	DrugMatrix			32644	Autocuration	BAO_0000219	12592	CHEMBL321	SINGLE PROTEIN	P14780	Matrix metalloproteinase 9	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802013	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774685	CHEMBL1909206	B	DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))	15	DrugMatrix			32644	Autocuration	BAO_0000219	10140	CHEMBL258	SINGLE PROTEIN	P06239	Tyrosine-protein kinase LCK	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799815	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774736	CHEMBL1909125	B	DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10579	CHEMBL2414	SINGLE PROTEIN	P51679	C-C chemokine receptor type 4	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	10947426	MIC	=	128	ug.mL-1		MIC	=	128	ug ml-1			0	BAO_0002146	UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	827367	CHEMBL2051037	F	Antimycobacterial activity against Mycobacterium tuberculosis H37Ra ATCC 25177 by microbroth dilution method	1	Scientific Literature	Mycobacterium tuberculosis H37Ra	ATCC 25177	419947	Autocuration	BAO_0000218	106765	CHEMBL2366634	ORGANISM		Mycobacterium tuberculosis H37Ra	Mycobacterium tuberculosis H37Ra	1	Non-molecular			62474	CHEMBL2046301	22633120	Bioorg. Med. Chem.	2012	20	13	4149					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1 (Thalidomide)	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	435712	IC50	=	500	nM	6.3	IC50	=	.5	uM			0	BAO_0000190	UO_0000065	http://www.openphacts.org/units/Nanomolar	157994	CHEMBL766667	B	Inhibitory activity (RA2) against Prostaglandin G/H synthase 2 was calculated relative to aspirin	1	Scientific Literature	Ovis aries		9940	Intermediate	BAO_0000357	17100	CHEMBL4102	SINGLE PROTEIN	P79208	Cyclooxygenase-2	Ovis aries	9	Protein	An_peroxidase	high	5412	CHEMBL1135264	11909713	Bioorg. Med. Chem. Lett.	2002	12	7	1043					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2045845	IC50	=	2040	nM	5.69	IC50	=	2.04	uM			0	BAO_0000190	UO_0000065	http://www.openphacts.org/units/Nanomolar	457693	CHEMBL925016	B	Inhibition of IL-1-alpha-induced NF-kappaB activation in HeLa cells assessed as blocking of p50/p65 nuclear translocation	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			37804	CHEMBL1140471	17845850	Bioorg. Med. Chem. Lett.	2007	17	21	6031	308	CHEMBL3308376	HeLa		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3233234	IC50	>	50000	nM		IC50	>	50	uM			0	BAO_0000190	UO_0000065	http://www.openphacts.org/units/Nanomolar	622767	CHEMBL1107706	F	Cytotoxicity against human HL60 cells by MTT assay	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	80156	CHEMBL383	CELL-LINE		HL-60	Homo sapiens	1	Non-molecular			49997	CHEMBL1153763	19394719	Eur. J. Med. Chem.	2009	44	9	3533	649	CHEMBL3307654	HL-60		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3363971	TIME	=	.001889	hr		Time	=	6.8	s			0		UO_0000032	http://qudt.org/vocab/unit#Hour	642717	CHEMBL1177009	F	Analgesic activity in Swiss mouse assessed as increase in latency of paw licking at 100 umol/kg, po after 120 mins measured for 60 seconds by hot plate test (Rvb = 5.6 +/- 0.5 seconds)	1	Scientific Literature	Mus musculus	Swiss	10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			51813	CHEMBL1177683	20598893	Bioorg. Med. Chem.	2010	18	14	5007					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3363955	TIME	=	.002083	hr		Time	=	7.5	s			0		UO_0000032	http://qudt.org/vocab/unit#Hour	642715	CHEMBL1177007	F	Analgesic activity in Swiss mouse assessed as increase in latency of paw licking at 100 umol/kg, po after 90 mins measured for 60 seconds by hot plate test (Rvb = 5.9 +/- 0.8 seconds)	1	Scientific Literature	Mus musculus	Swiss	10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			51813	CHEMBL1177683	20598893	Bioorg. Med. Chem.	2010	18	14	5007					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3363997	TIME	=	.01333	hr		Time	=	48	s			0		UO_0000032	http://qudt.org/vocab/unit#Hour	642713	CHEMBL1177005	F	Analgesic activity in Swiss mouse assessed as increase in latency of paw licking at 100 umol/kg, po after 60 mins measured for 60 seconds by hot plate test (Rvb = 4.9 +/- 0.5 seconds)	1	Scientific Literature	Mus musculus	Swiss	10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			51813	CHEMBL1177683	20598893	Bioorg. Med. Chem.	2010	18	14	5007					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	(+/-)-1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2673332	Activity	<	60	%		Activity	<	60	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	575149	CHEMBL1035528	F	Antiangiogenic activity against VEGF-induced HUVEC assessed as tube area at 100 uM after 11 days by BCIP/NBT visualization assay	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	81057	CHEMBL613979	CELL-LINE		HUVEC	Homo sapiens	1	Non-molecular			47527	CHEMBL1151853	19297157	Bioorg. Med. Chem. Lett.	2009	19	14	3973	473	CHEMBL3307501	HUVEC		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thl	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13460585	Activity	=	3.6	ug ml-1		Activity	=	3.6	ug ml-1			0	BAO_0000181	UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	984969	CHEMBL2433018	F	Immunomodulatory activity in BALB/c mouse splenocytes assessed as inhibition of LPS-induced nitric oxide production at 25 ug/ml after 72 hrs by Griess method relative to control	1	Scientific Literature	Mus musculus	BALB/c	10090	Autocuration	BAO_0000219	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			74939	CHEMBL2429842		Med Chem Res	2013			1	321	CHEMBL3307957	Splenocyte		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2474365	Activity	=	5.8	kU		Activity	=	5.8	kU			0	BAO_0000181			536011	CHEMBL990692	F	Increase in catalase activity per milligram of tissue in mouse Ehrlich ascites carcinoma cells implanted in Swiss albino mouse treated after 7 days post-tumor implantation at 1.25 mM/kg, sc for 5 days	1	Scientific Literature	Mus musculus	Swiss albino	10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			44747	CHEMBL1151683	18951804	Bioorg. Med. Chem.	2008	16	22	9708	666	CHEMBL3307669	Ehrlich		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2474302	Activity	=	20.5	%		Activity	=	20.5	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	536006	CHEMBL988022	F	Cytotoxicity against mouse Ehrlich ascites carcinoma cells assessed as viable cells at 10 uL after 24 hrs by trypan blue exclusion assay	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000219	80830	CHEMBL614641	CELL-LINE		Ehrlich	Mus musculus	1	Non-molecular			44747	CHEMBL1151683	18951804	Bioorg. Med. Chem.	2008	16	22	9708	666	CHEMBL3307669	Ehrlich		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2474359	Activity	=	330.2	nmol		Activity	=	330.2	nmol			0	BAO_0000181	UO_0000041		536010	CHEMBL990691	F	Decrease in lipid peroxidation in mouse Ehrlich ascites carcinoma cells implanted in Swiss albino mouse assessed as malondialdehyde per gram of tissue treated after 7 days post-tumor implantation at 1.25 mM/kg, sc for 5 days	1	Scientific Literature	Mus musculus	Swiss albino	10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			44747	CHEMBL1151683	18951804	Bioorg. Med. Chem.	2008	16	22	9708	666	CHEMBL3307669	Ehrlich		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	1437397	Inhibition	<	10	%		Inhibition	<	10	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	315768	CHEMBL825477	F	Inhibitory activity against tubulin polymerization at 20 uM	1	Scientific Literature	Sus scrofa		9823	Intermediate	BAO_0000218	50590	CHEMBL613488	ORGANISM		Sus scrofa	Sus scrofa	1	Non-molecular			20681	CHEMBL1140361	15603947	Bioorg. Med. Chem. Lett.	2005	15	2	321					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3106382	Inhibition	=	4	%		INH	=	4	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	610460	CHEMBL1064314	B	Inhibition of NF-kappaB-mediated TNF expression in human Jurkat T cells coexpressing GFP reporter gene at 10 uM by flow cytometry	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			49883	CHEMBL1159046	20034801	Bioorg. Med. Chem.	2010	18	2	650	503	CHEMBL3307526	Jurkat		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	1987741	Inhibition	=	31	%		Inhibition	=	31	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	449736	CHEMBL898841	F	Inhibition of TNF gene expression in FRT-Jurkat TNF reporter cells at 1 uM	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	81072	CHEMBL397	CELL-LINE		Jurkat	Homo sapiens	1	Non-molecular			37036	CHEMBL1137495	17851074	Bioorg. Med. Chem. Lett.	2007	17	21	5819	503	CHEMBL3307526	Jurkat		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thal	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8045411	Inhibition	=	77	%		INH	=	77	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	806522	CHEMBL1959655	B	Inhibition of NF-kappaB activation expressed in human HT-29 cells assessed as inhibition of TNFalpha-stimulated IL8 release at 200 uM after 24 hrs by flow cytometric analysis relative to control	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			61309	CHEMBL1955718	22356737	Bioorg. Med. Chem.	2012	20	6	2158	786	CHEMBL3307768	HT-29		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15035741	Inhibition	=	42.2	%		INH	=	42.2	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	1456285	CHEMBL3367808	F	Antinociceptive effect in mouse assessed as inhibition of acetic acid-induced abdominal constriction at 100 uM/kg, po	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			90230	CHEMBL3352176	24907144	Bioorg. Med. Chem. Lett.	2014	24	14	3084					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1 (Thalidomide)	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	612742	Inhibition	~	95	%		Inhibition	~	95	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	212404	CHEMBL816156	F	Inhibition of TNF-alpha production from human monocytes upon stimulation with bacterial lipopolysaccharide (LPS) at a concentration of 1 uM	1	Scientific Literature				Autocuration	BAO_0000019	185	CHEMBL1825	SINGLE PROTEIN	P01375	TNF-alpha	Homo sapiens	8	Homologous protein			13492	CHEMBL1129257	8759624	J. Med. Chem.	1996	39	16	3044					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	426454	Production	=	135	%		Production	=	135	%			0		UO_0000187	http://qudt.org/vocab/unit#Percent	79003	CHEMBL687571	F	Compound was evaluated for the amount of TNF-alpha produced by HL-60 cells in the presence of 12-O-tetradecanoylphorbol-13-acetate (TPA) at concentration 30 uM	1	Scientific Literature	Homo sapiens		9606	Intermediate	BAO_0000219	80156	CHEMBL383	CELL-LINE		HL-60	Homo sapiens	1	Non-molecular			1810	CHEMBL1129176		Bioorg. Med. Chem. Lett.	1996	6	19	2293	649	CHEMBL3307654	HL-60		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2373842	Flu intensity	=	468.37	-		Flu intensity	=	468.37				0				535237	CHEMBL981696	F	Antiinflammatory activity in mouse LPS-activated RAW264.7 cells assessed as mean fluorescent intensity of ROS scavenging activity at 10 uM pretreated for 3 hrs before LPS challenge by FACS	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000219	80418	CHEMBL612557	CELL-LINE		RAW264.7	Mus musculus	1	Non-molecular			44554	CHEMBL1144167	18723357	Bioorg. Med. Chem.	2008	16	18	8619	343	CHEMBL3307977	RAW264.7		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2373844	Activity					Activity				Active		0	BAO_0000375			535240	CHEMBL981699	F	Reduction in iNOS expression in LPS-activated mouse RAW264.7 cells at 10 uM pretreated for 3 hrs before LPS challenge assessed after 24 hrs by Western blot	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000219	80418	CHEMBL612557	CELL-LINE		RAW264.7	Mus musculus	1	Non-molecular			44554	CHEMBL1144167	18723357	Bioorg. Med. Chem.	2008	16	18	8619	343	CHEMBL3307977	RAW264.7		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID170465323	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15502388	AC50		19952.6	nM		AC50		19.9526	uM	inactive		0	BAO_0000186	UO_0000065	http://www.openphacts.org/units/Nanomolar	1495402	CHEMBL3562133	F	PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen1 green channel.   (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID170465323	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15479622	Ac50		1.413	uM		Ac50		1.4125375446	uM	inactive		0	BAO_0000186	UO_0000064	http://www.openphacts.org/units/Micromolar	1495354	CHEMBL3562085	F	PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, ratio channel.   (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8716079	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809044	CHEMBL1964030	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the K-562 Leukemia cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80186	CHEMBL385	CELL-LINE		K562	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							655	CHEMBL3308378	K562		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	9918323	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809324	CHEMBL1963876	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-268 Central Nervous System cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	81054	CHEMBL613977	CELL-LINE		SF-268	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							471	CHEMBL3307499	SF-268		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	9167516	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809086	CHEMBL1964072	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SW-620 Colon cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	81331	CHEMBL612262	CELL-LINE		SW-620	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							305	CHEMBL3307944	SW-620		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	10213734	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809349	CHEMBL1963901	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H460 Non-Small Cell Lung cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	81024	CHEMBL396	CELL-LINE		NCI-H460	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							676	CHEMBL3307677	NCI-H460		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID174007312	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	14009925	Potency		3.3	nM		Potency		.0033	uM	inactive		0	BAO_0000186	UO_0000065	http://www.openphacts.org/units/Nanomolar	1301420	CHEMBL3214945	F	PubChem BioAssay. qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (3D7) proliferation.   (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000019	22221	CHEMBL3879801	NON-MOLECULAR		Placeholder for assays where the target is a tissue/organism etc		1	Non-molecular			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID50104514	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	4941706	Potency	=	.3	nM		Potency	=	.0003	um	Inconclusive	Outside typical range	0	BAO_0000186	UO_0000065	http://www.openphacts.org/units/Nanomolar	688600	CHEMBL1614067	F	PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]	7	PubChem BioAssays	Homo sapiens		9606	Autocuration	BAO_0000019	103670	CHEMBL1293237	SINGLE PROTEIN	P54132	Bloom syndrome protein	Homo sapiens	9	Protein			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID124881523	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	12855932	Potency		29092.9	nM		Potency		29.0929	uM	inconclusive		0	BAO_0000186	UO_0000065	http://www.openphacts.org/units/Nanomolar	954272	CHEMBL2354221	F	PubChem BioAssay. qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13981522	Hepatotoxicity (acute)	=	2	-		Hepatotoxicity (acute)	=	2		references out of a total of 5		0				1301377	CHEMBL3137724	T	Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000221	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			77450	CHEMBL3137667	15646539	Gastroenterol Clin Biol	2004	28	8-9	720					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13981528	Hepatotoxicity (cirrhosis)	=	0	-		Hepatotoxicity (cirrhosis)	=	0		references out of a total of 5		0				1301383	CHEMBL3137730	T	Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			77450	CHEMBL3137667	15646539	Gastroenterol Clin Biol	2004	28	8-9	720					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13981531	Hepatotoxicity (steatosis)	=	0	-		Hepatotoxicity (steatosis)	=	0		references out of a total of 5		0				1301386	CHEMBL3137733	T	Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			77450	CHEMBL3137667	15646539	Gastroenterol Clin Biol	2004	28	8-9	720					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	5317890	Hepatotoxicity					Hepatotoxicity				drug-induced liver injury reported		0				736784	CHEMBL1697778	A	Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000221	103956	CHEMBL1697861	PHENOTYPE		Hepatotoxicity		1	Non-molecular			56111	CHEMBL1697731	20014752	Chem. Res. Toxicol.	2010	23	1	171					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346671	CK	=	112	U.L-1		CREATINE PHOSPHOKINASE	=	112	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CK (Creatine Kinase) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346699	CK	=	111.33	U.L-1		CREATINE PHOSPHOKINASE	=	111.33	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CK (Creatine Kinase) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345795	CK	=	148.33	U.L-1		CREATINE PHOSPHOKINASE	=	148.33	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CK (Creatine Kinase) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346694	ALP	=	271.67	U.L-1		ALKALINE PHOSPHATASE	=	271.67	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = ALP (Alkaline Phosphatase) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346692	ALT	=	36	U.L-1		ALANINE AMINOTRANSFERASE	=	36	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = ALT (Alanine Aminotransferase) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346611	AST	=	53.33	U.L-1		ASPARTATE AMINOTRANSFERASE	=	53.33	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = AST (Aspartate Aminotransferase) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346668	BUN	=	113.3	ug.mL-1		BLOOD UREA NITROGEN	=	11.33	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BUN (Blood Urea Nitrogen) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346627	HGB	=	134300	ug.mL-1		HEMOGLOBIN	=	13.43	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HGB (Hemoglobin) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346711	HGB	=	145000	ug.mL-1		HEMOGLOBIN	=	14.5	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HGB (Hemoglobin) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346714	MCH	=	20.23	pg		MEAN CORPUSCULAR HEMOGLOBIN	=	20.23	PG	See Activity_Supp For Individual Animal Data		0		UO_0000025		1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MCH (Ery. Mean Corpuscular Hemoglobin) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346716	MCV	=	63.47	fL		MEAN CORPUSCULAR VOLUME	=	63.47	FL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MCV (Ery. Mean Corpuscular Volume) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346625	RBC	=	6900000	cells.uL-1		ERYTHROCYTE COUNT	=	6.9	x10E6/uL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = RBC (Erythrocytes) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346705	BILI	=	3	ug.mL-1		TOTAL BILIRUBIN	=	.3	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BILI (Bilirubin) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345592	CHOL	=	711.7	ug.mL-1		CHOLESTEROL	=	71.17	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CHOL (Cholesterol) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345711	MCHC	=	304700	ug.mL-1		MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION	=	30.47	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MCHC (Ery. Mean Corpuscular HGB Concentration) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345816	PHOS	=	118	ug.mL-1		PHOSPHORUS	=	11.8	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PHOS (Phosphate) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346706	PROT	=	66300	ug.mL-1		TOTAL PROTEIN	=	6.63	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PROT (Protein) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346624	EOSLE	=	.27	%		EOSINOPHIL	=	.27	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = EOSLE (Eosinophils/Leukocytes) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345858	EOSLE	=	.43	%		EOSINOPHIL	=	.43	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = EOSLE (Eosinophils/Leukocytes) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345662	EOSLE	=	.98	%		EOSINOPHIL	=	.98	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = EOSLE (Eosinophils/Leukocytes) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346679	BASOLE	=	1.9	%		BASOPHIL	=	1.9	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BASOLE (Basophils/Leukocytes) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346651	BASOLE	=	2.03	%		BASOPHIL	=	2.03	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BASOLE (Basophils/Leukocytes) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346718	NEUTLE	=	13.9	%		NEUTROPHIL	=	13.9	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = NEUTLE (Neutrophils/Leukocytes) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345585	CHLORIDE	=	104.33	mEq.L-1		CHLORIDE	=	104.33	MEQ/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CHLORIDE (Chloride) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483292	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, CENTRILOBULAR, NECROSIS, ONCOCYTIC | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483296	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, MIDZONAL, LIPID ACCUMULATION, MICROVESICULAR | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483299	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, NONZONAL, DEGENERATION | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483314	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, PERIPORTAL, NECROSIS, APOPTOTIC | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483316	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, SUBCAPSULAR, MINERALIZATION | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483317	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, SUBCAPSULAR, NECROSIS, ONCOCYTIC | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483324	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PERIPORTAL, EDEMA | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799798	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774710	CHEMBL1909099	B	DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin)	15	DrugMatrix	Bacillus cereus		1396	Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801896	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774758	CHEMBL1909147	B	DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801970	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774663	CHEMBL1909184	B	DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP)	15	DrugMatrix	Homo sapiens		9606	Autocuration	BAO_0000221	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046							5578	CHEMBL3833781	Platelet		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799808	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774732	CHEMBL1909121	B	DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802002	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774679	CHEMBL1909200	B	DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)	15	DrugMatrix	Escherichia coli		562	Autocuration	BAO_0000357	11638	CHEMBL4040	SINGLE PROTEIN	P28482	MAP kinase ERK2	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799838	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774747	CHEMBL1909136	B	DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)	15	DrugMatrix			32644	Autocuration	BAO_0000219	11365	CHEMBL289	SINGLE PROTEIN	P10635	Cytochrome P450 2D6	Homo sapiens	9	Protein			59306	CHEMBL1909046							5579	CHEMBL3833782	BTI-TN-5B1-4		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799844	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774750	CHEMBL1909139	B	DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390)	15	DrugMatrix			32644	Autocuration	BAO_0000249	88	CHEMBL2056	SINGLE PROTEIN	P21728	Dopamine D1 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							449	CHEMBL3308072	CHO		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799762	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774692	CHEMBL1909213	B	DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX)	15	DrugMatrix			32644	Autocuration	BAO_0000249	114	CHEMBL226	SINGLE PROTEIN	P30542	Adenosine A1 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							449	CHEMBL3308072	CHO		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801944	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774650	CHEMBL1909171	B	DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	47	CHEMBL211	SINGLE PROTEIN	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801948	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774652	CHEMBL1909173	B	DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	214	CHEMBL1821	SINGLE PROTEIN	P08173	Muscarinic acetylcholine receptor M4	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801903	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774762	CHEMBL1909151	B	DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799797	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774710	CHEMBL1909099	B	DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin)	15	DrugMatrix	Bacillus cereus		1396	Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801905	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774763	CHEMBL1909152	B	DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801907	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774764	CHEMBL1909153	B	DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801923	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774772	CHEMBL1909161	B	DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta)	15	DrugMatrix			32644	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046							723	CHEMBL3307716	NIH3T3		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801977	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774667	CHEMBL1909188	B	DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF)	15	DrugMatrix			32644	Autocuration	BAO_0000219	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046							723	CHEMBL3307716	NIH3T3		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804080	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774717	CHEMBL1909106	B	DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630)	15	DrugMatrix			32644	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804102	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774728	CHEMBL1909117	B	DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)	15	DrugMatrix			32644	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046							379	CHEMBL3308006	U-937		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801965	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774661	CHEMBL1909182	B	DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	129	CHEMBL233	SINGLE PROTEIN	P35372	Mu opioid receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799837	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774747	CHEMBL1909136	B	DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)	15	DrugMatrix			32644	Autocuration	BAO_0000219	11365	CHEMBL289	SINGLE PROTEIN	P10635	Cytochrome P450 2D6	Homo sapiens	9	Protein			59306	CHEMBL1909046							5579	CHEMBL3833782	BTI-TN-5B1-4		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799839	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774748	CHEMBL1909137	B	DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)	15	DrugMatrix			32644	Autocuration	BAO_0000219	20056	CHEMBL5281	SINGLE PROTEIN	P05181	Cytochrome P450 2E1	Homo sapiens	9	Protein			59306	CHEMBL1909046							5579	CHEMBL3833782	BTI-TN-5B1-4		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801961	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774659	CHEMBL1909180	B	DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)	15	DrugMatrix			32644	Autocuration	BAO_0000249	136	CHEMBL236	SINGLE PROTEIN	P41143	Delta opioid receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804088	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774721	CHEMBL1909110	B	DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol)	15	DrugMatrix			32644	Autocuration	BAO_0000249	11272	CHEMBL287	SINGLE PROTEIN	Q99720	Sigma opioid receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							503	CHEMBL3307526	Jurkat		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799857	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774757	CHEMBL1909146	B	DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol)	15	DrugMatrix			32644	Autocuration	BAO_0000219	174	CHEMBL242	SINGLE PROTEIN	Q92731	Estrogen receptor beta	Homo sapiens	9	Protein			59306	CHEMBL1909046							1759	CHEMBL3308860	Sf9		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801933	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774645	CHEMBL1909166	B	DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH)	15	DrugMatrix			32644	Autocuration	BAO_0000249	11003	CHEMBL4644	SINGLE PROTEIN	P41968	Melanocortin receptor 3	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799783	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774703	CHEMBL1909092	B	DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)	15	DrugMatrix			32644	Autocuration	BAO_0000249	43	CHEMBL210	SINGLE PROTEIN	P07550	Beta-2 adrenergic receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							449	CHEMBL3308072	CHO		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799769	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774696	CHEMBL1909085	B	DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	12514	CHEMBL319	SINGLE PROTEIN	P43140	Alpha-1a adrenergic receptor	Rattus norvegicus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799775	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774699	CHEMBL1909088	B	DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)	15	DrugMatrix			32644	Autocuration	BAO_0000249	52	CHEMBL1867	SINGLE PROTEIN	P08913	Alpha-2a adrenergic receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							1759	CHEMBL3308860	Sf9		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799779	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774701	CHEMBL1909090	B	DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912)	15	DrugMatrix			32644	Autocuration	BAO_0000249	218	CHEMBL1916	SINGLE PROTEIN	P18825	Alpha-2c adrenergic receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							1759	CHEMBL3308860	Sf9		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802007	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774682	CHEMBL1909203	B	DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))	15	DrugMatrix			32644	Autocuration	BAO_0000219	9	CHEMBL203	SINGLE PROTEIN	P00533	Epidermal growth factor receptor erbB1	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	3	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	12664212	EC50	>	10000	nM		EC50	>	10	uM			0	BAO_0000188	UO_0000065	http://www.openphacts.org/units/Nanomolar	938957	CHEMBL2328539	F	Inhibition of IL-2 production in human T cells measured after 2 to 3 days by ELISA	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			72056	CHEMBL2321776	23168019	Bioorg. Med. Chem. Lett.	2013	23	1	360					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	22	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2234412	IC50	=	200000	nM		IC50	=	200	uM		Outside typical range	0	BAO_0000190	UO_0000065	http://www.openphacts.org/units/Nanomolar	511134	CHEMBL999605	F	Inhibition of TNFalpha release in human whole blood	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000221	102213	CHEMBL613416	TISSUE		Blood	Homo sapiens	1	Non-molecular			44321	CHEMBL1157355	18686943	J. Med. Chem.	2008	51	18	5471					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	16469727	IC50	=	10700	nM	4.97	IC50	=	10.7	uM			0	BAO_0000190	UO_0000065	http://www.openphacts.org/units/Nanomolar	1555518	CHEMBL3768100	B	Inhibition of MANT-uracil binding to Magnetospirillum gryphiswaldense cereblon isoform 4 Y101F mutant by FRET assay	1	Scientific Literature	Magnetospirillum gryphiswaldense		55518	Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			98322	CHEMBL3763149	26730808	J. Med. Chem.	2016	59	2	770					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	10 (Thalidomide)	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	778632	IC50	>	100	ug.mL-1		IC50	>	100	ug ml-1		Outside typical range	0	BAO_0000190	UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	215599	CHEMBL820867	F	The cytotoxicity assessed using human embryonic lung fibroblast WI-38 cells. 	1	Scientific Literature	Homo sapiens		9606	Intermediate	BAO_0000219	80589	CHEMBL614391	CELL-LINE		WI-38	Homo sapiens	1	Non-molecular			14079	CHEMBL1130136	9288167	J. Med. Chem.	1997	40	18	2858	603	CHEMBL3307614	WI-38		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3233232	IC50	>	50000	nM		IC50	>	50	uM			0	BAO_0000190	UO_0000065	http://www.openphacts.org/units/Nanomolar	622762	CHEMBL1107701	F	Cytotoxicity against human HT-29 cells by MTT assay	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	80166	CHEMBL384	CELL-LINE		HT-29	Homo sapiens	1	Non-molecular			49997	CHEMBL1153763	19394719	Eur. J. Med. Chem.	2009	44	9	3533	786	CHEMBL3307768	HT-29		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	75337	IC50	~	200000	nM		IC50	~	200	uM		Outside typical range	0	BAO_0000190	UO_0000065	http://www.openphacts.org/units/Nanomolar	212909	CHEMBL819936	F	Inhibition of LPS stimulated Tumor Necrosis Factor-alpha (TNF-alpha) release by human PBMC	1	Scientific Literature	Homo sapiens		9606	Expert	BAO_0000219	100081	CHEMBL613107	CELL-LINE		PBMC	Homo sapiens	1	Non-molecular			2788	CHEMBL1130594	9873600	Bioorg. Med. Chem. Lett.	1998	8	19	2669	394	CHEMBL3308021	PBMC		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3364014	TIME	=	.001639	hr		Time	=	5.9	s			0		UO_0000032	http://qudt.org/vocab/unit#Hour	642719	CHEMBL1177079	F	Analgesic activity in Swiss mouse assessed as increase in latency of paw licking at 100 umol/kg, po after 150 mins measured for 60 seconds by hot plate test (Rvb = 5.1 +/- 0.4 seconds)	1	Scientific Literature	Mus musculus	Swiss	10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			51813	CHEMBL1177683	20598893	Bioorg. Med. Chem.	2010	18	14	5007					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thal	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8045460	Activity	=	100	uM		Activity	=	100	uM			0	BAO_0000181	UO_0000064	http://www.openphacts.org/units/Micromolar	806387	CHEMBL1959229	A	Cytotoxicity against human HT-29 cells expressing NF-kappaB-hrGFP assessed as highest non-cytotoxic dose for 100% cell survival after 24 hrs by MTT assay	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	80166	CHEMBL384	CELL-LINE		HT-29	Homo sapiens	1	Non-molecular			61309	CHEMBL1955718	22356737	Bioorg. Med. Chem.	2012	20	6	2158	786	CHEMBL3307768	HT-29		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2474319	Activity	=	20.5	%		Activity	=	20.5	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	536007	CHEMBL988023	F	Cytotoxicity against mouse Ehrlich ascites carcinoma cells assessed as viable cells at 20 uL after 24 hrs by trypan blue exclusion assay	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000219	80830	CHEMBL614641	CELL-LINE		Ehrlich	Mus musculus	1	Non-molecular			44747	CHEMBL1151683	18951804	Bioorg. Med. Chem.	2008	16	22	9708	666	CHEMBL3307669	Ehrlich		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2373840	Activity	=	44.1	%		Activity	=	44.1	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	535235	CHEMBL991732	F	Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production at 10 uM pretreated for 3 hrs before LPS challenge assessed after 24 hrs by griess assay relative to control	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000219	80418	CHEMBL612557	CELL-LINE		RAW264.7	Mus musculus	1	Non-molecular			44554	CHEMBL1144167	18723357	Bioorg. Med. Chem.	2008	16	18	8619	343	CHEMBL3307977	RAW264.7		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3364091	Activity	=	46.6	%		Activity	=	46.6	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	642722	CHEMBL1177202	F	Antiedematogenic activity in Swiss mouse assessed as decrease of capsaicin-induced paw edema weight at 100 umol/kg, po administered 40 mins before capsaicin challenge measured after 30 mins relative to control	1	Scientific Literature	Mus musculus	Swiss	10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			51813	CHEMBL1177683	20598893	Bioorg. Med. Chem.	2010	18	14	5007					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	14545613	Inhibition	=	2	%		INH	=	2	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	1330158	CHEMBL3223786	B	Inhibition of NFkappaB in human FRT-Jurkat cells expressing GFP assessed as reduction of TNF expression at 10 uM after 24 hrs by flow cytometry relative to control	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	104730	CHEMBL2094258	PROTEIN COMPLEX GROUP	P19838, Q00653, Q04206	Nuclear factor NF-kappa-B complex	Homo sapiens	5	Multiple proteins			81833	CHEMBL3217613		MedChemComm	2011	2	11	1073					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thal	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8045436	Inhibition	=	63	%		INH	=	63	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	806518	CHEMBL1959651	B	Inhibition of NF-kappaB activation expressed in human HT-29 cells assessed as inhibition of TNFalpha-stimulated IL8 release at 100 uM after 24 hrs by flow cytometric analysis relative to control	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			61309	CHEMBL1955718	22356737	Bioorg. Med. Chem.	2012	20	6	2158	786	CHEMBL3307768	HT-29		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15035761	Inhibition	=	42.81	%		INH	=	42.81	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	1456287	CHEMBL3367810	F	Antiinflammatory activity against mouse L929 cells assessed as inhibition of LPS-induced TNFalpha production at 125 uM after 48 hrs	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000219	81137	CHEMBL612267	CELL-LINE		L929	Mus musculus	1	Non-molecular			90230	CHEMBL3352176	24907144	Bioorg. Med. Chem. Lett.	2014	24	14	3084	307	CHEMBL3307946	L929		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thl	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13460563	Inhibition	=	76.3	%		INH	=	76.3	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	984966	CHEMBL2433015	F	Antiinflammatory activity in carrageenan-induced air pouch mouse model assessed as inhibition of leukocyte migration from blood circulation into air pouches at 10 mg/kg, po administered 1 hr before carrageenan challenge measured after 6 hrs relative to control	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			74939	CHEMBL2429842		Med Chem Res	2013			1					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thal	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8045507	Inhibition	=	126	%		INH	=	126	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	806381	CHEMBL1959223	B	Inhibition of TNFalpha-induced NF-kappaB activation expressed in human HT-29 cells coexpressing hrGFP at 100 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis relative to control	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			61309	CHEMBL1955718	22356737	Bioorg. Med. Chem.	2012	20	6	2158	786	CHEMBL3307768	HT-29		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	2765	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	14759629	Solubility		154900	nM		Solubility		154.9	uM			0	BAO_0002135	UO_0000065	http://www.openphacts.org/units/Nanomolar	1369279	CHEMBL3301364	P	ASTRAZENECA: Solubility in pH7.4 buffer using solid starting material using the method described in J. Assoc. Lab. Autom. 2011, 16, 276-284. Experimental range 0.10 to 1500 uM	27	AstraZeneca Deposited Data				Autocuration	BAO_0000100	22229	CHEMBL2362975	NO TARGET		No relevant target		0	Unassigned			84147	CHEMBL3301361											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1 (Thal)	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	1481501	NBT positivity	=	1	%		NBT positivity	=	1	%			0		UO_0000187	http://qudt.org/vocab/unit#Percent	316734	CHEMBL838236	F	NBT positivity against human leukemia cell line HL-60 at 1*E-5 M	1	Scientific Literature	Homo sapiens		9606	Intermediate	BAO_0000219	80156	CHEMBL383	CELL-LINE		HL-60	Homo sapiens	1	Non-molecular			20525	CHEMBL1139643	15936192	Bioorg. Med. Chem. Lett.	2005	15	13	3212	649	CHEMBL3307654	HL-60		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13981521	Hepatotoxicity (moderate)	=	5.6	%		Hepatotoxicity (moderate)	=	5.6	%			0		UO_0000187	http://qudt.org/vocab/unit#Percent	1301376	CHEMBL3137723	T	Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000221	22221	CHEMBL3879801	NON-MOLECULAR		Placeholder for assays where the target is a tissue/organism etc		1	Non-molecular			77450	CHEMBL3137667	15646539	Gastroenterol Clin Biol	2004	28	8-9	720					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	16738613	Activity					Activity				Toxic		0	BAO_0000375			1614795	CHEMBL3856864	T	Cytotoxicity against BMOL-NT cells assessed as induction of cell death at 100 uM	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			101142	CHEMBL3856197	27208658	Eur J Med Chem	2016	120		275					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thl	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15620215	Inhibition					INH				Active		0	BAO_0000376			1498232	CHEMBL3583655	F	Inhibition of TNFalpha production in LPS-induced mouse peritoneal macrophages at 50 uM incubated for 24 hrs by sandwich ELISA method	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000219	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			92436	CHEMBL3580609		MedChemComm	2014	5	6	758	421	CHEMBL3308045	Peritoneal macrophage cell		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID170465323	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15480285	AC50		39810.7	nM		AC50		39.8107	uM	inactive		0	BAO_0000186	UO_0000065	http://www.openphacts.org/units/Nanomolar	1495388	CHEMBL3562119	F	PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 green channel.   (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	9846838	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809316	CHEMBL1963868	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HCT-15 Colon cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	81335	CHEMBL612263	CELL-LINE		HCT-15	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							306	CHEMBL3307945	HCT-15		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	10748537	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809428	CHEMBL1964009	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RXF 393 Renal cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80438	CHEMBL614886	CELL-LINE		RXF 393	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							743	CHEMBL3307734	RXF 393		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	10238157	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809351	CHEMBL1963903	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UACC-62 Melanoma cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80570	CHEMBL614610	CELL-LINE		UACC-62	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							657	CHEMBL3307660	UACC-62		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID174007312	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	14086178	Potency		5951.8	nM		Potency		5.9518	uM	inactive		0	BAO_0000186	UO_0000065	http://www.openphacts.org/units/Nanomolar	1301444	CHEMBL3215001	F	PubChem BioAssay. qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation.   (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000019	22221	CHEMBL3879801	NON-MOLECULAR		Placeholder for assays where the target is a tissue/organism etc		1	Non-molecular			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thal	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8046461	Activity					Activity				Non-toxic		0	BAO_0000375			806526	CHEMBL1959659	A	Pro-inflammatory activity in NFkappaB-GFP transfected human HT-29 cells at 25 to 400 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	80166	CHEMBL384	CELL-LINE		HT-29	Homo sapiens	1	Non-molecular			61309	CHEMBL1955718	22356737	Bioorg. Med. Chem.	2012	20	6	2158	786	CHEMBL3307768	HT-29		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	(+/-)-1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2673338	Activity					Activity				Not Active		0	BAO_0000375			575150	CHEMBL1035529	F	Antiangiogenic activity against VEGF-induced HUVEC assessed as tube length at 100 uM after 11 days after 11 days by BCIP/NBT visualization assay	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	81057	CHEMBL613979	CELL-LINE		HUVEC	Homo sapiens	1	Non-molecular			47527	CHEMBL1151853	19297157	Bioorg. Med. Chem. Lett.	2009	19	14	3973	473	CHEMBL3307501	HUVEC		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID50104514	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	4750025	Potency	=	.3	nM		Potency	=	.0003	um	Inconclusive	Outside typical range	0	BAO_0000186	UO_0000065	http://www.openphacts.org/units/Nanomolar	688259	CHEMBL1614522	F	PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 594 (Rhodamine region spectral profiling screen)]	7	PubChem BioAssays	Homo sapiens		9606	Autocuration	BAO_0000019	103670	CHEMBL1293237	SINGLE PROTEIN	P54132	Bloom syndrome protein	Homo sapiens	9	Protein			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	3	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	12664210	IC50					IC50				Not Determined		0	BAO_0000190			938958	CHEMBL2328540	F	Antiproliferative activity against human NAMALWA cells assessed as inhibition of [3H]thymidine incorporation after 72 hrs by scintillation counting	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	22221	CHEMBL3879801	NON-MOLECULAR		Placeholder for assays where the target is a tissue/organism etc		1	Non-molecular			72056	CHEMBL2321776	23168019	Bioorg. Med. Chem. Lett.	2013	23	1	360					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13981529	Hepatotoxicity (granulomatous hepatitis)	=	0	-		Hepatotoxicity (granulomatous hepatitis)	=	0		references out of a total of 5		0				1301384	CHEMBL3137731	T	Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000221	22221	CHEMBL3879801	NON-MOLECULAR		Placeholder for assays where the target is a tissue/organism etc		1	Non-molecular			77450	CHEMBL3137667	15646539	Gastroenterol Clin Biol	2004	28	8-9	720					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346615	CK	=	135.33	U.L-1		CREATINE PHOSPHOKINASE	=	135.33	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CK (Creatine Kinase) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345550	ALT	=	41	U.L-1		ALANINE AMINOTRANSFERASE	=	41	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = ALT (Alanine Aminotransferase) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346639	AST	=	57	U.L-1		ASPARTATE AMINOTRANSFERASE	=	57	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = AST (Aspartate Aminotransferase) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346640	BUN	=	120	ug.mL-1		BLOOD UREA NITROGEN	=	12	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BUN (Blood Urea Nitrogen) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345578	BUN	=	151.7	ug.mL-1		BLOOD UREA NITROGEN	=	15.17	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BUN (Blood Urea Nitrogen) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345676	HCT	=	44.65	%		HEMATOCRIT	=	44.65	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HCT (Hematocrit) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345669	RBC	=	6960000	cells.uL-1		ERYTHROCYTE COUNT	=	6.96	x10E6/uL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = RBC (Erythrocytes) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345886	WBC	=	9450	cells.uL-1		LEUKOCYTE COUNT	=	9.45	x10E3/uL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = WBC (Leukocytes) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346684	WBC	=	9530	cells.uL-1		LEUKOCYTE COUNT	=	9.53	x10E3/uL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = WBC (Leukocytes) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346677	BILI	=	3.3	ug.mL-1		TOTAL BILIRUBIN	=	.33	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BILI (Bilirubin) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346642	CHOL	=	623.3	ug.mL-1		CHOLESTEROL	=	62.33	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CHOL (Cholesterol) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345620	PHOS	=	112.3	ug.mL-1		PHOSPHORUS	=	11.23	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PHOS (Phosphate) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345802	CREAT	=	5.8	ug.mL-1		CREATININE	=	.58	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CREAT (Creatinine) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346708	EOSLE	=	.4	%		EOSINOPHIL	=	.4	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = EOSLE (Eosinophils/Leukocytes) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345697	LYMLE	=	76.48	%		LYMPHOCYTE	=	76.48	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = LYMLE (Lymphocytes/Leukocytes) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346657	LYMLE	=	80.43	%		LYMPHOCYTE	=	80.43	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = LYMLE (Lymphocytes/Leukocytes) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346629	LYMLE	=	84.1	%		LYMPHOCYTE	=	84.1	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = LYMLE (Lymphocytes/Leukocytes) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346707	BASOLE	=	1.4	%		BASOPHIL	=	1.4	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BASOLE (Basophils/Leukocytes) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345781	CHLORIDE	=	103.17	mEq.L-1		CHLORIDE	=	103.17	MEQ/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CHLORIDE (Chloride) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346669	CHLORIDE	=	103.33	mEq.L-1		CHLORIDE	=	103.33	MEQ/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CHLORIDE (Chloride) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346619	POTASSIUM	=	6.87	mEq.L-1		POTASSIUM	=	6.87	MEQ/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = POTASSIUM (Potassium) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483273	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = AUTOLYSIS | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483282	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CENTRILOBULAR, INFLAMMATORY CELL INFILTRATE, MIXED CELL | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	5329154	Phospholipidosis					Phospholipidosis				Negative: based on the absence of positive reported data from WMDD		0				736802	CHEMBL1697855	A	Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset	1	Scientific Literature				Autocuration	BAO_0000019	103779	CHEMBL1626541	PHENOTYPE		Phospholipidosis		1	Non-molecular			56126	CHEMBL1697821	20020916	Toxicol. Mech. Methods	2008	18	2	217					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801968	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774662	CHEMBL1909183	B	DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu)	15	DrugMatrix	Mus musculus	ICR	10090	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801910	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774765	CHEMBL1909154	B	DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801972	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774664	CHEMBL1909185	B	DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP)	15	DrugMatrix			32644	Autocuration	BAO_0000219	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046							379	CHEMBL3308006	U-937		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801956	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774656	CHEMBL1909177	B	DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046							652	CHEMBL3307656	IMR-32		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804103	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774728	CHEMBL1909117	B	DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)	15	DrugMatrix			32644	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046							379	CHEMBL3308006	U-937		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801990	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774673	CHEMBL1909194	B	DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)	15	DrugMatrix	Homo sapiens		9606	Autocuration	BAO_0000221	10494	CHEMBL4071	SINGLE PROTEIN	P08311	Cathepsin G	Homo sapiens	9	Protein			59306	CHEMBL1909046							428	CHEMBL3308052	Neutrophil		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799790	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774706	CHEMBL1909095	B	DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde)	15	DrugMatrix	Rattus norvegicus		10116	Autocuration	BAO_0000221	12543	CHEMBL2622	SINGLE PROTEIN	P07943	Aldose reductase	Rattus norvegicus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801912	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774766	CHEMBL1909155	B	DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	109556	CHEMBL3392921	PROTEIN COMPLEX GROUP	P07727, P20781, P22771, P24524	Glycine receptor	Rattus norvegicus	5	Multiple proteins			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801922	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774771	CHEMBL1909160	B	DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	101214	CHEMBL5486	SINGLE PROTEIN	P15127	Insulin receptor	Rattus norvegicus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799842	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774749	CHEMBL1909138	B	DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)	15	DrugMatrix			32644	Autocuration	BAO_0000219	17045	CHEMBL340	SINGLE PROTEIN	P08684	Cytochrome P450 3A4	Homo sapiens	9	Protein			59306	CHEMBL1909046							5579	CHEMBL3833782	BTI-TN-5B1-4		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799856	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774756	CHEMBL1909145	B	DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol)	15	DrugMatrix			32644	Autocuration	BAO_0000219	19	CHEMBL206	SINGLE PROTEIN	P03372	Estrogen receptor alpha	Homo sapiens	9	Protein			59306	CHEMBL1909046							1759	CHEMBL3308860	Sf9		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801936	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774646	CHEMBL1909167	B	DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10142	CHEMBL259	SINGLE PROTEIN	P32245	Melanocortin receptor 4	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801938	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774647	CHEMBL1909168	B	DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH)	15	DrugMatrix			32644	Autocuration	BAO_0000249	11006	CHEMBL4608	SINGLE PROTEIN	P33032	Melanocortin receptor 5	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799820	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774738	CHEMBL1909127	B	DRUGMATRIX: Chemokine CXCR1 (IL-8A)	15	DrugMatrix			32644	Autocuration	BAO_0000357	11574	CHEMBL4029	SINGLE PROTEIN	P25024	Interleukin-8 receptor A	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799770	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774696	CHEMBL1909085	B	DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	12514	CHEMBL319	SINGLE PROTEIN	P43140	Alpha-1a adrenergic receptor	Rattus norvegicus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799776	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774699	CHEMBL1909088	B	DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912)	15	DrugMatrix			32644	Autocuration	BAO_0000249	52	CHEMBL1867	SINGLE PROTEIN	P08913	Alpha-2a adrenergic receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							1759	CHEMBL3308860	Sf9		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799778	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774700	CHEMBL1909089	B	DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	216	CHEMBL1942	SINGLE PROTEIN	P18089	Alpha-2b adrenergic receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799780	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774701	CHEMBL1909090	B	DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912)	15	DrugMatrix			32644	Autocuration	BAO_0000249	218	CHEMBL1916	SINGLE PROTEIN	P18825	Alpha-2c adrenergic receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							1759	CHEMBL3308860	Sf9		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799814	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774735	CHEMBL1909124	B	DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1)	15	DrugMatrix			32644	Autocuration	BAO_0000249	11575	CHEMBL4015	SINGLE PROTEIN	P41597	C-C chemokine receptor type 2	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804077	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774715	CHEMBL1909104	B	DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide)	15	DrugMatrix			32644	Autocuration	BAO_0000249	227	CHEMBL1833	SINGLE PROTEIN	P41595	Serotonin 2b (5-HT2b) receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801981	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774669	CHEMBL1909190	B	DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)	15	DrugMatrix			32644	Autocuration	BAO_0000249	165	CHEMBL240	SINGLE PROTEIN	Q12809	HERG	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804090	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774722	CHEMBL1909111	B	DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802001	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774679	CHEMBL1909200	B	DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)	15	DrugMatrix	Escherichia coli		562	Autocuration	BAO_0000357	11638	CHEMBL4040	SINGLE PROTEIN	P28482	MAP kinase ERK2	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801991	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774674	CHEMBL1909195	B	DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)	15	DrugMatrix	Homo sapiens		9606	Autocuration	BAO_0000221	235	CHEMBL248	SINGLE PROTEIN	P08246	Leukocyte elastase	Homo sapiens	9	Protein			59306	CHEMBL1909046							428	CHEMBL3308052	Neutrophil		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801939	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774648	CHEMBL1909169	B	DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine)	15	DrugMatrix			32644	Autocuration	BAO_0000219	86	CHEMBL1951	SINGLE PROTEIN	P21397	Monoamine oxidase A	Homo sapiens	9	Protein			59306	CHEMBL1909046							5579	CHEMBL3833782	BTI-TN-5B1-4		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799849	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774753	CHEMBL1909142	B	DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone)	15	DrugMatrix			32644	Autocuration	BAO_0000249	90	CHEMBL219	SINGLE PROTEIN	P21917	Dopamine D4 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799765	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774694	CHEMBL1909215	B	DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)	15	DrugMatrix			32644	Autocuration	BAO_0000249	280	CHEMBL256	SINGLE PROTEIN	P0DMS8	Adenosine A3 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799811	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774734	CHEMBL1909123	B	DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA))	15	DrugMatrix	Homo sapiens		9606	Autocuration	BAO_0000221	15	CHEMBL205	SINGLE PROTEIN	P00918	Carbonic anhydrase II	Homo sapiens	9	Protein			59306	CHEMBL1909046							5555	CHEMBL3833281	Erythrocyte		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801983	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774670	CHEMBL1909191	B	DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020)	15	DrugMatrix	Bos taurus		9913	Autocuration	BAO_0000221	104322	CHEMBL1909044	SINGLE PROTEIN	Q690N0	Progesterone receptor	Bos taurus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804100	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774727	CHEMBL1909116	B	DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2)	15	DrugMatrix	Homo sapiens		9606	Autocuration	BAO_0000221	248	CHEMBL1835	SINGLE PROTEIN	P24557	Thromboxane-A synthase	Homo sapiens	9	Protein			59306	CHEMBL1909046							5578	CHEMBL3833781	Platelet		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801901	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774761	CHEMBL1909150	B	DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone)	15	DrugMatrix			32644	Autocuration	BAO_0000219	25	CHEMBL2034	SINGLE PROTEIN	P04150	Glucocorticoid receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							5587	CHEMBL3886002	HeLa S3		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801935	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774646	CHEMBL1909167	B	DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10142	CHEMBL259	SINGLE PROTEIN	P32245	Melanocortin receptor 4	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804108	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774731	CHEMBL1909120	B	DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)	15	DrugMatrix			32644	Autocuration	BAO_0000249	134	CHEMBL1889	SINGLE PROTEIN	P37288	Vasopressin V1a receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799823	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774740	CHEMBL1909129	B	DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10472	CHEMBL1901	SINGLE PROTEIN	P32238	Cholecystokinin A receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804082	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774718	CHEMBL1909107	B	DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808)	15	DrugMatrix	Cavia porcellus	Dunkin-Hartley	10141	Autocuration	BAO_0000249	20033	CHEMBL5017	SINGLE PROTEIN	O70528	Serotonin 4 (5-HT4) receptor	Cavia porcellus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804084	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774719	CHEMBL1909108	B	DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10627	CHEMBL3371	SINGLE PROTEIN	P50406	Serotonin 6 (5-HT6) receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							308	CHEMBL3308376	HeLa		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801951	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774654	CHEMBL1909175	B	DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10475	CHEMBL4777	SINGLE PROTEIN	P25929	Neuropeptide Y receptor type 1	Homo sapiens	9	Protein			59306	CHEMBL1909046							531	CHEMBL3307551	SK-N-MC		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804106	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774730	CHEMBL1909119	B	DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP)	15	DrugMatrix			32644	Autocuration	BAO_0000249	100334	CHEMBL5144	SINGLE PROTEIN	P32241	Vasoactive intestinal polypeptide receptor 1	Homo sapiens	9	Protein			59306	CHEMBL1909046							786	CHEMBL3307768	HT-29		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	16738584	GI50	=	100000	nM		GI50	=	100	uM			0	BAO_0000189	UO_0000065	http://www.openphacts.org/units/Nanomolar	1614815	CHEMBL3856884	A	Growth inhibition of BMOL-NT cells	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000219	22221	CHEMBL3879801	NON-MOLECULAR		Placeholder for assays where the target is a tissue/organism etc		1	Non-molecular			101142	CHEMBL3856197	27208658	Eur J Med Chem	2016	120		275					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1 (Thalidomide)	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	435711	IC50	=	370	nM	6.43	IC50	=	.37	uM			0	BAO_0000190	UO_0000065	http://www.openphacts.org/units/Nanomolar	159404	CHEMBL763457	B	Inhibitory activity (RA1) against Prostaglandin G/H synthase 1 was calculated relative to aspirin	1	Scientific Literature	Ovis aries		9940	Intermediate	BAO_0000357	17047	CHEMBL2949	SINGLE PROTEIN	P05979	Cyclooxygenase-1	Ovis aries	9	Protein	An_peroxidase	high	5412	CHEMBL1135264	11909713	Bioorg. Med. Chem. Lett.	2002	12	7	1043					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	3	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	12664214	IC50	=	77000	nM	4.11	IC50	=	77	uM			0	BAO_0000190	UO_0000065	http://www.openphacts.org/units/Nanomolar	938959	CHEMBL2328541	F	Inhibition of TNF-alpha production in LPS-stimulated human PBMC preincubated for 1 hr before LPS challenge measured after 28 to 20 hrs by ELISA	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	100081	CHEMBL613107	CELL-LINE		PBMC	Homo sapiens	1	Non-molecular			72056	CHEMBL2321776	23168019	Bioorg. Med. Chem. Lett.	2013	23	1	360	394	CHEMBL3308021	PBMC		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3233233	IC50	>	50000	nM		IC50	>	50	uM			0	BAO_0000190	UO_0000065	http://www.openphacts.org/units/Nanomolar	622766	CHEMBL1107705	F	Cytotoxicity against human ST486 cells by MTT assay	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	106462	CHEMBL2366293	CELL-LINE		ST486	Homo sapiens	1	Non-molecular			49997	CHEMBL1153763	19394719	Eur. J. Med. Chem.	2009	44	9	3533	1554	CHEMBL3308887	ST486		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3106398	Activity	=	6	%		Activity	=	6	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	610467	CHEMBL1064321	F	Cytotoxicity against human Jurkat T cells assessed as cell death at 10 uM after 24 hrs by flow cytometry	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	81072	CHEMBL397	CELL-LINE		Jurkat	Homo sapiens	1	Non-molecular			49883	CHEMBL1159046	20034801	Bioorg. Med. Chem.	2010	18	2	650	503	CHEMBL3307526	Jurkat		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3106397	Activity	=	7	%		Activity	=	7	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	610466	CHEMBL1064320	F	Cytotoxicity against human Jurkat T cells assessed as cell death at 100 uM after 24 hrs by flow cytometry	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	81072	CHEMBL397	CELL-LINE		Jurkat	Homo sapiens	1	Non-molecular			49883	CHEMBL1159046	20034801	Bioorg. Med. Chem.	2010	18	2	650	503	CHEMBL3307526	Jurkat		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2474377	Activity	=	44	%		Activity	=	44	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	536013	CHEMBL990694	F	Antitumor activity against mouse Ehrlich ascites carcinoma cells implanted in Swiss albino mouse assessed as tumor necrosis treated after 7 days post-tumor implantation at 1.25 mM/kg, sc for 5 days by histopathological analysis relative to control	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000218	80830	CHEMBL614641	CELL-LINE		Ehrlich	Mus musculus	1	Non-molecular			44747	CHEMBL1151683	18951804	Bioorg. Med. Chem.	2008	16	22	9708	666	CHEMBL3307669	Ehrlich		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thl	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13460567	Activity	>	100	ug ml-1		Activity	>	100	ug ml-1			0	BAO_0000181	UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	984971	CHEMBL2433020	A	Cytotoxicity against BALB/c mouse splenocytes assessed as highest nontoxic concentration after 24 hrs by [3H]-thymidine incorporation assay	1	Scientific Literature	Mus musculus	BALB/c	10090	Autocuration	BAO_0000219	22224	CHEMBL612558	ADMET		ADMET		0	Unassigned			74939	CHEMBL2429842		Med Chem Res	2013			1	321	CHEMBL3307957	Splenocyte		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	363008	Inhibition	<	5	%		Inhibition	<	5	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	49935	CHEMBL660318	B	Inhibition of chymotrypsin at 250 uM	1	Scientific Literature	unidentified		32644	Expert	BAO_0000357	11685	CHEMBL2386	SINGLE PROTEIN	Q99895	Chymotrypsin C	Homo sapiens	8	Homologous protein			17239	CHEMBL1145124	14521410	J. Med. Chem.	2003	46	21	4477					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	363007	Inhibition	<	5	%		Inhibition	<	5	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	40717	CHEMBL653602	B	Inhibition of beta-lactamase at 100 uM	1	Scientific Literature				Expert	BAO_0000357	10027	CHEMBL2026	SINGLE PROTEIN	P00811	Beta-lactamase AmpC	Escherichia coli K-12	8	Homologous protein			17239	CHEMBL1145124	14521410	J. Med. Chem.	2003	46	21	4477					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	14545642	Inhibition	=	4	%		INH	=	4	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	1330159	CHEMBL3223787	B	Inhibition of NFkappaB in human FRT-Jurkat cells expressing GFP assessed as reduction of TNF expression at 100 uM after 24 hrs by flow cytometry relative to control	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	104730	CHEMBL2094258	PROTEIN COMPLEX GROUP	P19838, Q00653, Q04206	Nuclear factor NF-kappa-B complex	Homo sapiens	5	Multiple proteins			81833	CHEMBL3217613		MedChemComm	2011	2	11	1073					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thl	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15619576	Inhibition	=	5	%		INH	=	5	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	1498234	CHEMBL3583657	F	Inhibition of TNFalpha expression in human Jurkat cells containing GFP gene under control of TNF gene promoter at 100 uM incubated for 24 hrs	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	81072	CHEMBL397	CELL-LINE		Jurkat	Homo sapiens	1	Non-molecular			92436	CHEMBL3580609		MedChemComm	2014	5	6	758	503	CHEMBL3307526	Jurkat		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	1987740	Inhibition	=	35	%		Inhibition	=	35	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	449735	CHEMBL898836	F	Inhibition of TNF gene expression in FRT Jurkat TNF reporter cells at 10 uM	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	81072	CHEMBL397	CELL-LINE		Jurkat	Homo sapiens	1	Non-molecular			37036	CHEMBL1137495	17851074	Bioorg. Med. Chem. Lett.	2007	17	21	5819	503	CHEMBL3307526	Jurkat		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3218631	Inhibition	=	14.19	%		INH	=	14.19	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	619306	CHEMBL1099470	B	Inhibition of human FAAH at 1 uM	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000357	11291	CHEMBL2243	SINGLE PROTEIN	O00519	Anandamide amidohydrolase	Homo sapiens	9	Protein			50231	CHEMBL1154381	19850474	Bioorg. Med. Chem. Lett.	2009	19	23	6793					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3364069	Inhibition	=	25.2	%		INH	=	25.2	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	642723	CHEMBL1177203	F	Antiedematogenic activity in Swiss mouse assessed as inhibition of capsaicin-induced paw edema at 100 umol/kg, po administered 40 mins before capsaicin challenge measured after 30 mins relative to control	1	Scientific Literature	Mus musculus	Swiss	10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			51813	CHEMBL1177683	20598893	Bioorg. Med. Chem.	2010	18	14	5007					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3364567	Inhibition	=	66.7	%		INH	=	66.7	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	642712	CHEMBL1177004	F	Analgesic activity against formalin-induced acute pain in Swiss mouse assessed inhibition of nociception at 100 umol/kg, po administered 40 mins before formalin challenge measured for 15 to 30 mins relative to control	1	Scientific Literature	Mus musculus	Swiss	10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			51813	CHEMBL1177683	20598893	Bioorg. Med. Chem.	2010	18	14	5007					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thl	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13460594	Inhibition	=	72.1	%		INH	=	72.1	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	984972	CHEMBL2433021	F	Antiinflammatory activity in carrageenan-induced air pouch mouse model assessed as inhibition of leukocyte migration from blood circulation into air pouches at 100 mg/kg, po administered 1 hr before carrageenan challenge measured after 6 hrs relative to control	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			74939	CHEMBL2429842		Med Chem Res	2013			1					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2474353	Inhibition	=	80.6	%		INH	=	80.6	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	536009	CHEMBL990690	F	Antitumor activity against mouse Ehrlich ascites carcinoma cells implanted in Swiss albino mouse treated after 7 days post-tumor implantation at 1.25 mM/kg, sc for 5 days relative to control	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000218	80830	CHEMBL614641	CELL-LINE		Ehrlich	Mus musculus	1	Non-molecular			44747	CHEMBL1151683	18951804	Bioorg. Med. Chem.	2008	16	22	9708	666	CHEMBL3307669	Ehrlich		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13799377	Inhibition	=	82.94	%		Inhibition	=	82.93918945	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	1265862	CHEMBL3039488	A	Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM	1	Scientific Literature	Cricetulus griseus		10029	Autocuration	BAO_0000219	103947	CHEMBL1697668	SINGLE PROTEIN	Q9Y6L6	Solute carrier organic anion transporter family member 1B1	Homo sapiens	8	Homologous protein			75466	CHEMBL3039007	23571415	Mol. Pharmacol.	2013	83	6	1257	449	CHEMBL3308072	CHO		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1 (Thalidomide)	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	612745	Inhibition	~	64	%		Inhibition	~	64	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	212407	CHEMBL871927	F	Inhibition of TNF-alpha production from human monocytes upon stimulation with bacterial lipopolysaccharide (LPS) at a concentration of 200 uM	1	Scientific Literature				Autocuration	BAO_0000019	185	CHEMBL1825	SINGLE PROTEIN	P01375	TNF-alpha	Homo sapiens	8	Homologous protein			13492	CHEMBL1129257	8759624	J. Med. Chem.	1996	39	16	3044					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	426455	Production	=	58	%		Production	=	58	%			0		UO_0000187	http://qudt.org/vocab/unit#Percent	79005	CHEMBL687573	F	Compound was evaluated for the amount of TNF-alpha produced by HL-60 cells in the presence of Okadaic acid (OA) at concentration 30 uM	1	Scientific Literature	Homo sapiens		9606	Intermediate	BAO_0000219	80156	CHEMBL383	CELL-LINE		HL-60	Homo sapiens	1	Non-molecular			1810	CHEMBL1129176		Bioorg. Med. Chem. Lett.	1996	6	19	2293	649	CHEMBL3307654	HL-60		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7834123	HepSE_bilirubinemia	=	1	-		HepSE_bilirubinemia	=	1				0				774785	CHEMBL1909307	A	Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia	1	Scientific Literature				Autocuration	BAO_0000221	103956	CHEMBL1697861	PHENOTYPE		Hepatotoxicity		1	Non-molecular			59327	CHEMBL1909294	22194678	PLOS Computational Biology	2011	7	12	1					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7834136	HepSE_Combined Scores	=	4	-		HepSE_Combined Scores	=	4				0				774798	CHEMBL1909320	A	Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score	1	Scientific Literature				Autocuration	BAO_0000221	103956	CHEMBL1697861	PHENOTYPE		Hepatotoxicity		1	Non-molecular			59327	CHEMBL1909294	22194678	PLOS Computational Biology	2011	7	12	1					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13981523	Hepatotoxicity (acute)	=	0	%		Hepatotoxicity (acute)	=	0	%			0		UO_0000187	http://qudt.org/vocab/unit#Percent	1301378	CHEMBL3137725	T	Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000221	22221	CHEMBL3879801	NON-MOLECULAR		Placeholder for assays where the target is a tissue/organism etc		1	Non-molecular			77450	CHEMBL3137667	15646539	Gastroenterol Clin Biol	2004	28	8-9	720					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13981538	Hepatotoxicity (mechanism)					Hepatotoxicity (mechanism)					Potential missing data	0				1301393	CHEMBL3137740	T	Proposed mechanism(s) of liver damage. [column 'MEC' in source]	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000221	22221	CHEMBL3879801	NON-MOLECULAR		Placeholder for assays where the target is a tissue/organism etc		1	Non-molecular			77450	CHEMBL3137667	15646539	Gastroenterol Clin Biol	2004	28	8-9	720					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7834135	HepSE_liver function tests abnormal	=	0	-		HepSE_liver function tests abnormal	=	0				0				774797	CHEMBL1909319	A	Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal	1	Scientific Literature				Autocuration	BAO_0000221	103956	CHEMBL1697861	PHENOTYPE		Hepatotoxicity		1	Non-molecular			59327	CHEMBL1909294	22194678	PLOS Computational Biology	2011	7	12	1					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3364614	Activity					Activity				Active		0	BAO_0000375			642724	CHEMBL1177204	F	Antiinflammatory effect in complete Freund's adjuvant-induced Wistar rat arthritis model assessed as inhibition of paw edema at 100 umol/kg, po daily once administered on day 14 post adjuvant challenge measured on day 16 post adjuvant challenge	1	Scientific Literature	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000218	50597	CHEMBL376	ORGANISM		Rattus norvegicus	Rattus norvegicus	1	Non-molecular			51813	CHEMBL1177683	20598893	Bioorg. Med. Chem.	2010	18	14	5007					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3364616	Activity					Activity				Active		0	BAO_0000375			642725	CHEMBL1177205	F	Antiinflammatory effect in complete Freund's adjuvant-induced Wistar rat arthritis model assessed as inhibition of paw edema at 100 umol/kg, po daily once administered on day 14 post adjuvant challenge measured on day 17 post adjuvant challenge	1	Scientific Literature	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000218	50597	CHEMBL376	ORGANISM		Rattus norvegicus	Rattus norvegicus	1	Non-molecular			51813	CHEMBL1177683	20598893	Bioorg. Med. Chem.	2010	18	14	5007					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID170465323	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15519700	Ac50		19.95	uM		Ac50		19.9526231497	uM	inactive		0	BAO_0000186	UO_0000064	http://www.openphacts.org/units/Micromolar	1495357	CHEMBL3562088	F	PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen1, green channel.   (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	10013098	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809328	CHEMBL1963880	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the EKVX Non-Small Cell Lung cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80834	CHEMBL614487	CELL-LINE		EKVX	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							616	CHEMBL3307626	EKVX 		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	10500856	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809401	CHEMBL1963953	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the 786-0 Renal cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80640	CHEMBL613102	CELL-LINE		786-0	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							391	CHEMBL3308018	786-0		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8882697	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809061	CHEMBL1964047	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the U251 Central Nervous System cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80560	CHEMBL615022	CELL-LINE		U-251	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							770	CHEMBL3307756	U-251		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8388557	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809023	CHEMBL1963990	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80575	CHEMBL614388	CELL-LINE		UO-31	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							601	CHEMBL3307612	UO-31		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	10323367	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809359	CHEMBL1963911	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CAKI-1 Renal cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80055	CHEMBL614067	CELL-LINE		CAKI-1	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							498	CHEMBL3307522	CAKI-1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8541563	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809031	CHEMBL1964017	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80125	CHEMBL613508	CELL-LINE		DU-145	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							408	CHEMBL3308034	DU-145		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	10389072	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809370	CHEMBL1963922	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-295 Central Nervous System cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80468	CHEMBL614908	CELL-LINE		SF-295	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							747	CHEMBL3307738	SF-295		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	10365590	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809377	CHEMBL1963929	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the IGROV1 Ovarian cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	81065	CHEMBL613984	CELL-LINE		IGROV-1	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							474	CHEMBL3307502	IGROV-1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	10125576	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809343	CHEMBL1963895	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-OV-3 Ovarian cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80493	CHEMBL614925	CELL-LINE		SK-OV-3	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							757	CHEMBL3307746	SK-OV-3		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID11532929	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	6671285	Potency		2936.2	nM		Potency		2.9362	uM	inactive		0	BAO_0000186	UO_0000065	http://www.openphacts.org/units/Nanomolar	752407	CHEMBL1794345	F	PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850]	7	PubChem BioAssays	Plasmodium falciparum		5833	Autocuration	BAO_0000218	50425	CHEMBL364	ORGANISM		Plasmodium falciparum	Plasmodium falciparum	1	Non-molecular			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	(+/-)-1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2673340	Activity					Activity				Not Active		0	BAO_0000375			575152	CHEMBL1035531	F	Antiangiogenic activity against VEGF-induced HUVEC assessed as tube path at 100 uM after 11 days after 11 days by BCIP/NBT visualization assay	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	81057	CHEMBL613979	CELL-LINE		HUVEC	Homo sapiens	1	Non-molecular			47527	CHEMBL1151853	19297157	Bioorg. Med. Chem. Lett.	2009	19	14	3973	473	CHEMBL3307501	HUVEC		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID50104514	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	4166461	Potency	=	39810.7	nM	4.4	Potency	=	39.8107	um	Inconclusive		0	BAO_0000186	UO_0000065	http://www.openphacts.org/units/Nanomolar	688238	CHEMBL1614458	F	PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))]	7	PubChem BioAssays	Homo sapiens		9606	Autocuration	BAO_0000019	11130	CHEMBL3577	SINGLE PROTEIN	P00352	Aldehyde dehydrogenase 1A1	Homo sapiens	9	Protein			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13981527	Hepatotoxicity (chronic liver disease)	=	0	-		Hepatotoxicity (chronic liver disease)	=	0		references out of a total of 5		0				1301382	CHEMBL3137729	T	Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000221	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			77450	CHEMBL3137667	15646539	Gastroenterol Clin Biol	2004	28	8-9	720					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345599	CK	=	123.5	U.L-1		CREATINE PHOSPHOKINASE	=	123.5	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CK (Creatine Kinase) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346609	ALB	=	36300	ug.mL-1		ALBUMIN	=	3.63	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = ALB (Albumin) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345557	ALB	=	37700	ug.mL-1		ALBUMIN	=	3.77	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = ALB (Albumin) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345753	ALB	=	37700	ug.mL-1		ALBUMIN	=	3.77	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = ALB (Albumin) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346666	ALP	=	320.33	U.L-1		ALKALINE PHOSPHATASE	=	320.33	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = ALP (Alkaline Phosphatase) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345564	ALP	=	411.83	U.L-1		ALKALINE PHOSPHATASE	=	411.83	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = ALP (Alkaline Phosphatase) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346608	ALT	=	33	U.L-1		ALANINE AMINOTRANSFERASE	=	33	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = ALT (Alanine Aminotransferase) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345746	ALT	=	42.17	U.L-1		ALANINE AMINOTRANSFERASE	=	42.17	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = ALT (Alanine Aminotransferase) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346696	BUN	=	96.7	ug.mL-1		BLOOD UREA NITROGEN	=	9.67	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BUN (Blood Urea Nitrogen) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346654	HCT	=	42.57	%		HEMATOCRIT	=	42.57	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HCT (Hematocrit) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346655	HGB	=	134700	ug.mL-1		HEMOGLOBIN	=	13.47	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HGB (Hemoglobin) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345690	WBC	=	9830	cells.uL-1		LEUKOCYTE COUNT	=	9.83	x10E3/uL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = WBC (Leukocytes) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346628	WBC	=	12100	cells.uL-1		LEUKOCYTE COUNT	=	12.1	x10E3/uL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = WBC (Leukocytes) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346656	WBC	=	11430	cells.uL-1		LEUKOCYTE COUNT	=	11.43	x10E3/uL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = WBC (Leukocytes) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345641	BILI	=	5.7	ug.mL-1		TOTAL BILIRUBIN	=	.57	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BILI (Bilirubin) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346687	MCHC	=	315000	ug.mL-1		MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION	=	31.5	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MCHC (Ery. Mean Corpuscular HGB Concentration) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346622	PROT	=	62700	ug.mL-1		TOTAL PROTEIN	=	6.27	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PROT (Protein) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345648	PROT	=	68500	ug.mL-1		TOTAL PROTEIN	=	6.85	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PROT (Protein) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346700	CREAT	=	5.3	ug.mL-1		CREATININE	=	.53	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CREAT (Creatinine) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345606	CREAT	=	5.5	ug.mL-1		CREATININE	=	.55	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CREAT (Creatinine) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346661	MONOLE	=	3.03	%		MONOCYTE	=	3.03	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MONOLE (Monocytes/Leukocytes) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345830	SODIUM	=	148.33	mEq.L-1		SODIUM	=	148.33	MEQ/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = SODIUM (Sodium) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346676	SODIUM	=	148.67	mEq.L-1		SODIUM	=	148.67	MEQ/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = SODIUM (Sodium) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346613	CHLORIDE	=	103	mEq.L-1		CHLORIDE	=	103	MEQ/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CHLORIDE (Chloride) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345627	POTASSIUM	=	7.03	mEq.L-1		POTASSIUM	=	7.03	MEQ/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = POTASSIUM (Potassium) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483272	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = SINGLE HEPATOCYTE NECROSIS | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483277	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CAPSULE, INFLAMMATORY CELL INFILTRATE, MIXED CELL | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483278	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CAPSULE, MESOTHELIAL CELL, HYPERPLASIA | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483280	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CENTRILOBULAR FIBROSIS | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483289	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, CENTRILOBULAR, LIPID ACCUMULATION, MACROVESICULAR | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483290	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, CENTRILOBULAR, LIPID ACCUMULATION, MICROVESICULAR | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483293	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, DIFFUSE, CYTOPLASM, EOSINOPHILIA | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483303	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, NONZONAL, LIPID ACCUMULATION, MACROVESICULAR | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483308	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, NONZONAL, NECROSIS, ONCOCYTIC | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483313	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, PERIPORTAL, LIPID ACCUMULATION, MICROVESICULAR | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483320	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = NONZONAL, INFLAMMATORY CELL INFILTRATE, GRANULOMATOUS | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483321	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = NONZONAL, INFLAMMATORY CELL INFILTRATE, LYMPHOID | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799794	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774708	CHEMBL1909097	B	DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)	15	DrugMatrix	Sus scrofa		9823	Autocuration	BAO_0000221	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799804	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774713	CHEMBL1909102	B	DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799768	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774695	CHEMBL1909084	B	DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine)	15	DrugMatrix	Cavia porcellus	Dunkin-Hartley	10141	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799828	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774742	CHEMBL1909131	B	DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid)	15	DrugMatrix			32644	Autocuration	BAO_0000219	126	CHEMBL230	SINGLE PROTEIN	P35354	Cyclooxygenase-2	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799832	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774744	CHEMBL1909133	B	DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)	15	DrugMatrix			32644	Autocuration	BAO_0000219	20073	CHEMBL5282	SINGLE PROTEIN	P11509	Cytochrome P450 2A6	Homo sapiens	9	Protein			59306	CHEMBL1909046							5579	CHEMBL3833782	BTI-TN-5B1-4		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799760	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774691	CHEMBL1909212	B	DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine)	15	DrugMatrix			32644	Autocuration	BAO_0000219	93	CHEMBL220	SINGLE PROTEIN	P22303	Acetylcholinesterase	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802004	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774680	CHEMBL1909201	B	DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)	15	DrugMatrix	Escherichia coli		562	Autocuration	BAO_0000357	10188	CHEMBL260	SINGLE PROTEIN	Q16539	MAP kinase p38 alpha	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799766	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774694	CHEMBL1909215	B	DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA)	15	DrugMatrix			32644	Autocuration	BAO_0000249	280	CHEMBL256	SINGLE PROTEIN	P0DMS8	Adenosine A3 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801914	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774767	CHEMBL1909156	B	DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	127	CHEMBL231	SINGLE PROTEIN	P35367	Histamine H1 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804087	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774720	CHEMBL1909109	B	DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	121	CHEMBL228	SINGLE PROTEIN	P31645	Serotonin transporter	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799800	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774711	CHEMBL1909100	B	DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10034	CHEMBL3157	SINGLE PROTEIN	P30411	Bradykinin B2 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804101	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774727	CHEMBL1909116	B	DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2)	15	DrugMatrix	Homo sapiens		9606	Autocuration	BAO_0000221	248	CHEMBL1835	SINGLE PROTEIN	P24557	Thromboxane-A synthase	Homo sapiens	9	Protein			59306	CHEMBL1909046							5578	CHEMBL3833781	Platelet		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799822	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774739	CHEMBL1909128	B	DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10773	CHEMBL2434	SINGLE PROTEIN	P25025	Interleukin-8 receptor B	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802016	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774686	CHEMBL1909207	B	DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)	15	DrugMatrix	Escherichia coli		562	Autocuration	BAO_0000357	12088	CHEMBL3243	SINGLE PROTEIN	P08575	Leukocyte common antigen	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802024	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774690	CHEMBL1909211	B	DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin)	15	DrugMatrix			32644	Autocuration	BAO_0000249	107	CHEMBL224	SINGLE PROTEIN	P28223	Serotonin 2a (5-HT2a) receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804079	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774716	CHEMBL1909105	B	DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	108	CHEMBL225	SINGLE PROTEIN	P28335	Serotonin 2c (5-HT2c) receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801960	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774658	CHEMBL1909179	B	DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)	15	DrugMatrix	Escherichia coli		562	Autocuration	BAO_0000357	11039	CHEMBL3464	SINGLE PROTEIN	P29477	Nitric oxide synthase, inducible	Mus musculus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801987	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774672	CHEMBL1909193	B	DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)	15	DrugMatrix	Escherichia coli		562	Autocuration	BAO_0000357	11624	CHEMBL4801	SINGLE PROTEIN	P29466	Caspase-1	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801979	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774668	CHEMBL1909189	B	DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide)	15	DrugMatrix			32644	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799767	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774695	CHEMBL1909084	B	DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine)	15	DrugMatrix	Cavia porcellus	Dunkin-Hartley	10141	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801989	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774673	CHEMBL1909194	B	DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)	15	DrugMatrix	Homo sapiens		9606	Autocuration	BAO_0000221	10494	CHEMBL4071	SINGLE PROTEIN	P08311	Cathepsin G	Homo sapiens	9	Protein			59306	CHEMBL1909046							428	CHEMBL3308052	Neutrophil		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801999	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774678	CHEMBL1909199	B	DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)	15	DrugMatrix	Escherichia coli		562	Autocuration	BAO_0000357	11639	CHEMBL3385	SINGLE PROTEIN	P27361	MAP kinase ERK1	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799789	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774706	CHEMBL1909095	B	DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde)	15	DrugMatrix	Rattus norvegicus		10116	Autocuration	BAO_0000221	12543	CHEMBL2622	SINGLE PROTEIN	P07943	Aldose reductase	Rattus norvegicus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799825	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774741	CHEMBL1909130	B	DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid)	15	DrugMatrix	Homo sapiens		9606	Autocuration	BAO_0000221	96	CHEMBL221	SINGLE PROTEIN	P23219	Cyclooxygenase-1	Homo sapiens	9	Protein			59306	CHEMBL1909046							5578	CHEMBL3833781	Platelet		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799827	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774742	CHEMBL1909131	B	DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid)	15	DrugMatrix			32644	Autocuration	BAO_0000219	126	CHEMBL230	SINGLE PROTEIN	P35354	Cyclooxygenase-2	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799831	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774744	CHEMBL1909133	B	DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)	15	DrugMatrix			32644	Autocuration	BAO_0000219	20073	CHEMBL5282	SINGLE PROTEIN	P11509	Cytochrome P450 2A6	Homo sapiens	9	Protein			59306	CHEMBL1909046							5579	CHEMBL3833782	BTI-TN-5B1-4		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799847	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774752	CHEMBL1909141	B	DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone)	15	DrugMatrix			32644	Autocuration	BAO_0000249	130	CHEMBL234	SINGLE PROTEIN	P35462	Dopamine D3 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							449	CHEMBL3308072	CHO		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799809	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774733	CHEMBL1909122	B	DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A)	15	DrugMatrix			32644	Autocuration	BAO_0000249	87	CHEMBL218	SINGLE PROTEIN	P21554	Cannabinoid CB1 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799771	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774697	CHEMBL1909086	B	DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	12474	CHEMBL315	SINGLE PROTEIN	P15823	Alpha-1b adrenergic receptor	Rattus norvegicus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799773	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774698	CHEMBL1909087	B	DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin)	15	DrugMatrix			32644	Autocuration	BAO_0000249	103	CHEMBL223	SINGLE PROTEIN	P25100	Alpha-1d adrenergic receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801953	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774655	CHEMBL1909176	B	DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10477	CHEMBL4018	SINGLE PROTEIN	P49146	Neuropeptide Y receptor type 2	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804078	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774716	CHEMBL1909105	B	DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	108	CHEMBL225	SINGLE PROTEIN	P28335	Serotonin 2c (5-HT2c) receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801945	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774651	CHEMBL1909172	B	DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	219	CHEMBL245	SINGLE PROTEIN	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	5082025	CL	=	3.4	mL.min-1.kg-1		CL	=	3.4	mL/min/kg			0	BAO_0002759			688903	CHEMBL1614671	A	Clearance in human after iv administration	1	Scientific Literature	Homo sapiens		9606	Expert	BAO_0000218	22224	CHEMBL612558	ADMET		ADMET		0	Unassigned			54149	CHEMBL1614632	18426954	Drug Metab. Dispos.	2008	36	7	1385					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	5080270	Fu	=	.4	-		fu	=	.4				0				688904	CHEMBL1614672	A	Fraction unbound in human after iv administration	1	Scientific Literature	Homo sapiens		9606	Expert	BAO_0000218	22221	CHEMBL3879801	NON-MOLECULAR		Placeholder for assays where the target is a tissue/organism etc		1	Non-molecular			54149	CHEMBL1614632	18426954	Drug Metab. Dispos.	2008	36	7	1385					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	16738617	GI					GI					Potential missing data	0	BAO_0000181			1614794	CHEMBL3856863	F	Anticancer activity against BMOL-T cells assessed as cell growth inhibition up to 100 uM	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000219	22221	CHEMBL3879801	NON-MOLECULAR		Placeholder for assays where the target is a tissue/organism etc		1	Non-molecular			101142	CHEMBL3856197	27208658	Eur J Med Chem	2016	120		275					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	16469728	Ki	=	4400	nM	5.36	Ki	=	4.4	uM			0	BAO_0000192	UO_0000065	http://www.openphacts.org/units/Nanomolar	1555519	CHEMBL3768101	B	Inhibition of MANT-uracil binding to wild type Magnetospirillum gryphiswaldense cereblon isoform 4 by Cheng-Prusoff equation analysis	1	Scientific Literature	Magnetospirillum gryphiswaldense		55518	Autocuration	BAO_0000357	116733	CHEMBL3763007	SINGLE PROTEIN	A4TVL0	Cereblon isoform 4	Magnetospirillum gryphiswaldense	9	Protein			98322	CHEMBL3763149	26730808	J. Med. Chem.	2016	59	2	770					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	16469731	Ki	=	9600	nM	5.02	Ki	=	9.6	uM			0	BAO_0000192	UO_0000065	http://www.openphacts.org/units/Nanomolar	1555522	CHEMBL3768104	B	Inhibition of MANT-uracil binding to Magnetospirillum gryphiswaldense cereblon isoform 4 Y101F mutant by Cheng-Prusoff equation analysis	1	Scientific Literature	Magnetospirillum gryphiswaldense		55518	Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			98322	CHEMBL3763149	26730808	J. Med. Chem.	2016	59	2	770					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	5082225	MRT	=	4.3	hr		MRT	=	4.3	h			0		UO_0000032	http://qudt.org/vocab/unit#Hour	688905	CHEMBL1614673	A	Mean residence time in human after iv administration	1	Scientific Literature	Homo sapiens		9606	Expert	BAO_0000218	22224	CHEMBL612558	ADMET		ADMET		0	Unassigned			54149	CHEMBL1614632	18426954	Drug Metab. Dispos.	2008	36	7	1385					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	16469724	IC50	=	7800	nM	5.11	IC50	=	7.8	uM			0	BAO_0000190	UO_0000065	http://www.openphacts.org/units/Nanomolar	1555515	CHEMBL3768097	B	Inhibition of MANT-uracil binding to wild type Magnetospirillum gryphiswaldense cereblon isoform 4 by FRET assay	1	Scientific Literature	Magnetospirillum gryphiswaldense		55518	Autocuration	BAO_0000357	116733	CHEMBL3763007	SINGLE PROTEIN	A4TVL0	Cereblon isoform 4	Magnetospirillum gryphiswaldense	9	Protein			98322	CHEMBL3763149	26730808	J. Med. Chem.	2016	59	2	770					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	800711	IC50	>	2	nM		IC50	>	2	nM			0	BAO_0000190	UO_0000065	http://www.openphacts.org/units/Nanomolar	206517	CHEMBL807976	F	Inhibition of LPS-induced Tumor necrosis factor-alpha production (TNF-alpha) in THP-1 cells	1	Scientific Literature	Homo sapiens		9606	Intermediate	BAO_0000219	80548	CHEMBL614245	CELL-LINE		THP-1	Homo sapiens	1	Non-molecular			3079	CHEMBL1130806	9871710	Bioorg. Med. Chem. Lett.	1998	8	9	1071	559	CHEMBL3307574	THP-1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	75338	IC50	>	500000	nM		IC50	>	500	uM		Outside typical range	0	BAO_0000190	UO_0000065	http://www.openphacts.org/units/Nanomolar	155720	CHEMBL760598	B	Inhibition of PDE4 enzyme from U937 cells	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	104679	CHEMBL2093863	PROTEIN FAMILY	P27815, Q07343, Q08493, Q08499	Phosphodiesterase 4	Homo sapiens	5	Multiple proteins			2788	CHEMBL1130594	9873600	Bioorg. Med. Chem. Lett.	1998	8	19	2669	379	CHEMBL3308006	U-937		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2474383	Activity	=	.003	-		Activity	=	.003				0	BAO_0000181			536004	CHEMBL988020	F	Antitumor activity against mouse Ehrlich ascites carcinoma cells implanted in Swiss albino mouse assessed as tumor apoptotic index treated after 7 days post-tumor implantation at 1.25 mM/kg, sc for 5 days by histopathological analysis	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000218	80830	CHEMBL614641	CELL-LINE		Ehrlich	Mus musculus	1	Non-molecular			44747	CHEMBL1151683	18951804	Bioorg. Med. Chem.	2008	16	22	9708	666	CHEMBL3307669	Ehrlich		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2474389	Activity	=	.006	-		Activity	=	.006				0	BAO_0000181			536019	CHEMBL990700	F	Antitumor activity against mouse Ehrlich ascites carcinoma cells implanted in Swiss albino mouse assessed as tumor mitotic index treated after 7 days post-tumor implantation at 1.25 mM/kg, sc for 5 days by histopathological analysis	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000218	80830	CHEMBL614641	CELL-LINE		Ehrlich	Mus musculus	1	Non-molecular			44747	CHEMBL1151683	18951804	Bioorg. Med. Chem.	2008	16	22	9708	666	CHEMBL3307669	Ehrlich		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2474336	Activity	=	56.4	%		Activity	=	56.4	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	536008	CHEMBL990689	F	Cytotoxicity against mouse Ehrlich ascites carcinoma cells assessed as viable cells at 30 uL after 24 hrs by trypan blue exclusion assay	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000219	80830	CHEMBL614641	CELL-LINE		Ehrlich	Mus musculus	1	Non-molecular			44747	CHEMBL1151683	18951804	Bioorg. Med. Chem.	2008	16	22	9708	666	CHEMBL3307669	Ehrlich		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	(+/-)-1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2673375	Activity	=	85.9	%		Activity	=	85.9	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	575156	CHEMBL1023652	F	Cytotoxicity against human HS-Sultan cells assessed as cell viability at 100 ug/ml after 72 hrs by MTT assay	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	22221	CHEMBL3879801	NON-MOLECULAR		Placeholder for assays where the target is a tissue/organism etc		1	Non-molecular			47527	CHEMBL1151853	19297157	Bioorg. Med. Chem. Lett.	2009	19	14	3973					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15035771	Inhibition	=	35.38	%		INH	=	35.38	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	1456288	CHEMBL3367811	F	Antiinflammatory activity against mouse L929 cells assessed as inhibition of LPS-induced TNFalpha production at 15.625 uM after 48 hrs	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000219	81137	CHEMBL612267	CELL-LINE		L929	Mus musculus	1	Non-molecular			90230	CHEMBL3352176	24907144	Bioorg. Med. Chem. Lett.	2014	24	14	3084	307	CHEMBL3307946	L929		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3364099	Inhibition	=	61.3	%		INH	=	61.3	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	642721	CHEMBL1177201	F	Antiinflammatory activity against zymosan A-induced peritonitis in Swiss mouse assessed as inhibition of granulocyte infiltration in to peritoneal cavity at 100 mg/kg, po administered 40 mins before zymosan A challenge measured after 6 hrs relative to control	1	Scientific Literature	Mus musculus	Swiss	10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			51813	CHEMBL1177683	20598893	Bioorg. Med. Chem.	2010	18	14	5007					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thal	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8045476	Inhibition	=	114	%		INH	=	114	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	806385	CHEMBL1959227	B	Inhibition of TNFalpha-induced NF-kappaB activation expressed in human HT-29 cells coexpressing hrGFP at 200 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis relative to control	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			61309	CHEMBL1955718	22356737	Bioorg. Med. Chem.	2012	20	6	2158	786	CHEMBL3307768	HT-29		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3233119	Inhibition	=	164	%		INH	=	164	%		Outside typical range	0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	622764	CHEMBL1107703	F	Inhibition of okadaic acid-induced TNFalpha production in human HL60 cells at 30 uM after 16 hrs by ELISA relative to control	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	80156	CHEMBL383	CELL-LINE		HL-60	Homo sapiens	1	Non-molecular			49997	CHEMBL1153763	19394719	Eur. J. Med. Chem.	2009	44	9	3533	649	CHEMBL3307654	HL-60		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1 (Thalidomide)	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	612743	Inhibition	~	90	%		Inhibition	~	90	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	212405	CHEMBL816157	F	Inhibition of TNF-alpha production from human monocytes upon stimulation with bacterial lipopolysaccharide (LPS) at a concentration of 10 uM	1	Scientific Literature				Autocuration	BAO_0000019	185	CHEMBL1825	SINGLE PROTEIN	P01375	TNF-alpha	Homo sapiens	8	Homologous protein			13492	CHEMBL1129257	8759624	J. Med. Chem.	1996	39	16	3044					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7834132	HepSE_jaundice	=	1	-		HepSE_jaundice	=	1				0				774794	CHEMBL1909316	A	Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice	1	Scientific Literature				Autocuration	BAO_0000221	103956	CHEMBL1697861	PHENOTYPE		Hepatotoxicity		1	Non-molecular			59327	CHEMBL1909294	22194678	PLOS Computational Biology	2011	7	12	1					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	10 (Thalidomide)	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	778630	Amount of TNF-alpha	=	135	%		Amount of TNF-alpha	=	135	%			0		UO_0000187	http://qudt.org/vocab/unit#Percent	78452	CHEMBL687762	F	Tumor necrosis factor-alpha production in human leukemia cell line (HL-60) stimulated with 10 nM 12-O-tetradecanoylphorbol 13-acetate (TPA) at 30 uMolar.	1	Scientific Literature	Homo sapiens		9606	Expert	BAO_0000219	80156	CHEMBL383	CELL-LINE		HL-60	Homo sapiens	1	Non-molecular			14079	CHEMBL1130136	9288167	J. Med. Chem.	1997	40	18	2858	649	CHEMBL3307654	HL-60		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7834124	HepSE_cholecystitis	=	0	-		HepSE_cholecystitis	=	0				0				774786	CHEMBL1909308	A	Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis	1	Scientific Literature				Autocuration	BAO_0000221	103956	CHEMBL1697861	PHENOTYPE		Hepatotoxicity		1	Non-molecular			59327	CHEMBL1909294	22194678	PLOS Computational Biology	2011	7	12	1					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3364618	Activity					Activity				Active		0	BAO_0000375			642726	CHEMBL1177206	F	Antiinflammatory effect in complete Freund's adjuvant-induced Wistar rat arthritis model assessed as inhibition of paw edema at 100 umol/kg, po daily once administered on day 14 post adjuvant challenge measured on day 21 post adjuvant challenge	1	Scientific Literature	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000218	50597	CHEMBL376	ORGANISM		Rattus norvegicus	Rattus norvegicus	1	Non-molecular			51813	CHEMBL1177683	20598893	Bioorg. Med. Chem.	2010	18	14	5007					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID170465323	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15595642	AC50		631	nM		AC50		.631	uM	inactive		0	BAO_0000186	UO_0000065	http://www.openphacts.org/units/Nanomolar	1495415	CHEMBL3562146	F	PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 ratio channel.   (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID170465323	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15591540	Ac50		.631	uM		Ac50		.630957345	uM	inactive		0	BAO_0000186	UO_0000064	http://www.openphacts.org/units/Micromolar	1495421	CHEMBL3562152	F	PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen2, ratio channel.   (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8266207	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809009	CHEMBL1963976	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	81246	CHEMBL614078	CELL-LINE		MDA-N	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							509	CHEMBL3307532	MDA-N		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	9560091	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809113	CHEMBL1964099	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the BT-549 Breast cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	81316	CHEMBL614072	CELL-LINE		BT-549	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							789	CHEMBL3308490	BT-549		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	9046281	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809073	CHEMBL1964059	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-19 Central Nervous System cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80499	CHEMBL614164	CELL-LINE		SNB-19	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							532	CHEMBL3307552	SNB-19		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8356341	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809018	CHEMBL1963985	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	81281	CHEMBL614997	CELL-LINE		NCI-H23	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							763	CHEMBL3307750	NCI-H23		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8992246	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809062	CHEMBL1964048	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-8 Ovarian cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80357	CHEMBL612555	CELL-LINE		OVCAR-8	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							341	CHEMBL3307975	OVCAR-8		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	9655385	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809292	CHEMBL1963844	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-2 Melanoma cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80482	CHEMBL614917	CELL-LINE		SK-MEL-2	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							753	CHEMBL3307743	SK-MEL-2		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	10482374	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809408	CHEMBL1963960	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UACC-257 Melanoma cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80568	CHEMBL612796	CELL-LINE		UACC-257	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							381	CHEMBL3308008	UACC-257		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2488357	Activity					Activity				Not Active		0	BAO_0000375			519690	CHEMBL950912	F	Antiangiogenesis activity against MOG peptide, pertussis toxin, Mycobacterium tuberculosis-induced experimental allergic encephalomyelitis C57BL/6J mouse model assessed as inhibition of multiple sclerosis at 100 mg/kg up to 15 days	1	Scientific Literature	Mus musculus	C57BL/6J	10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			45564	CHEMBL1143283	19103485	Bioorg. Med. Chem. Lett.	2009	19	3	878					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13981520	Hepatotoxicity (moderate)	=	3	-		Hepatotoxicity (moderate)	=	3		references out of a total of 5		0				1301375	CHEMBL3137722	T	Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000221	22221	CHEMBL3879801	NON-MOLECULAR		Placeholder for assays where the target is a tissue/organism etc		1	Non-molecular			77450	CHEMBL3137667	15646539	Gastroenterol Clin Biol	2004	28	8-9	720					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346665	ALB	=	37000	ug.mL-1		ALBUMIN	=	3.7	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = ALB (Albumin) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346636	ALT	=	37	U.L-1		ALANINE AMINOTRANSFERASE	=	37	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = ALT (Alanine Aminotransferase) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346664	ALT	=	35.67	U.L-1		ALANINE AMINOTRANSFERASE	=	35.67	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = ALT (Alanine Aminotransferase) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346667	AST	=	57	U.L-1		ASPARTATE AMINOTRANSFERASE	=	57	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = AST (Aspartate Aminotransferase) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346695	AST	=	60	U.L-1		ASPARTATE AMINOTRANSFERASE	=	60	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = AST (Aspartate Aminotransferase) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346626	HCT	=	43.27	%		HEMATOCRIT	=	43.27	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HCT (Hematocrit) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346683	HGB	=	145000	ug.mL-1		HEMOGLOBIN	=	14.5	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HGB (Hemoglobin) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345704	MCH	=	19.57	pg		MEAN CORPUSCULAR HEMOGLOBIN	=	19.57	PG	See Activity_Supp For Individual Animal Data		0		UO_0000025		1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MCH (Ery. Mean Corpuscular Hemoglobin) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346660	MCV	=	62.13	fL		MEAN CORPUSCULAR VOLUME	=	62.13	FL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MCV (Ery. Mean Corpuscular Volume) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346653	RBC	=	6850000	cells.uL-1		ERYTHROCYTE COUNT	=	6.85	x10E6/uL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = RBC (Erythrocytes) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346709	RBC	=	7150000	cells.uL-1		ERYTHROCYTE COUNT	=	7.15	x10E6/uL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = RBC (Erythrocytes) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346701	GLUC	=	1673.3	ug.mL-1		GLUCOSE	=	167.33	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = GLUC (Glucose) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346617	GLUC	=	1773.3	ug.mL-1		GLUCOSE	=	177.33	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = GLUC (Glucose) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346645	GLUC	=	1876.7	ug.mL-1		GLUCOSE	=	187.67	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = GLUC (Glucose) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346673	GLUC	=	1876.7	ug.mL-1		GLUCOSE	=	187.67	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = GLUC (Glucose) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346691	PLAT	=	1553330	cells.uL-1		PLATELET COUNT	=	1553.33	x10E3/uL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PLAT (Platelets) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346650	PROT	=	61300	ug.mL-1		TOTAL PROTEIN	=	6.13	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PROT (Protein) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346652	EOSLE	=	.3	%		EOSINOPHIL	=	.3	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = EOSLE (Eosinophils/Leukocytes) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346689	MONOLE	=	2.07	%		MONOCYTE	=	2.07	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MONOLE (Monocytes/Leukocytes) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346634	NEUTLE	=	11.37	%		NEUTROPHIL	=	11.37	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = NEUTLE (Neutrophils/Leukocytes) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346648	SODIUM	=	146.33	mEq.L-1		SODIUM	=	146.33	MEQ/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = SODIUM (Sodium) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346647	POTASSIUM	=	6.03	mEq.L-1		POTASSIUM	=	6.03	MEQ/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = POTASSIUM (Potassium) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483285	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, CENTRILOBULAR, CYTOPLASM, EOSINOPHILIA | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483307	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, NONZONAL, NECROSIS, APOPTOTIC | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483310	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, PERIPORTAL, GLYCOGEN ACCUMULATION | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483318	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MALIGNANT LYMPHOMA | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804091	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774722	CHEMBL1909111	B	DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801924	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774772	CHEMBL1909161	B	DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta)	15	DrugMatrix			32644	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046							723	CHEMBL3307716	NIH3T3		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802018	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774687	CHEMBL1909208	B	DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)	15	DrugMatrix	Oryctolagus cuniculus	New Zealand albino	9986	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801940	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774648	CHEMBL1909169	B	DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine)	15	DrugMatrix			32644	Autocuration	BAO_0000219	86	CHEMBL1951	SINGLE PROTEIN	P21397	Monoamine oxidase A	Homo sapiens	9	Protein			59306	CHEMBL1909046							5579	CHEMBL3833782	BTI-TN-5B1-4		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799846	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774751	CHEMBL1909140	B	DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone)	15	DrugMatrix			32644	Autocuration	BAO_0000249	72	CHEMBL217	SINGLE PROTEIN	P14416	Dopamine D2 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							449	CHEMBL3308072	CHO		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799852	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774754	CHEMBL1909143	B	DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55)	15	DrugMatrix			32644	Autocuration	BAO_0000249	155	CHEMBL238	SINGLE PROTEIN	Q01959	Dopamine transporter	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801964	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774660	CHEMBL1909181	B	DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	137	CHEMBL237	SINGLE PROTEIN	P41145	Kappa opioid receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804097	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774725	CHEMBL1909114	B	DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10184	CHEMBL2327	SINGLE PROTEIN	P21452	Neurokinin 2 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							449	CHEMBL3308072	CHO		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799810	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774733	CHEMBL1909122	B	DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A)	15	DrugMatrix			32644	Autocuration	BAO_0000249	87	CHEMBL218	SINGLE PROTEIN	P21554	Cannabinoid CB1 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799824	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774740	CHEMBL1909129	B	DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10472	CHEMBL1901	SINGLE PROTEIN	P32238	Cholecystokinin A receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801996	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774676	CHEMBL1909197	B	DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)	15	DrugMatrix			32644	Autocuration	BAO_0000219	12592	CHEMBL321	SINGLE PROTEIN	P14780	Matrix metalloproteinase 9	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799788	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774705	CHEMBL1909094	B	DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55)	15	DrugMatrix			32644	Autocuration	BAO_0000249	100	CHEMBL222	SINGLE PROTEIN	P23975	Norepinephrine transporter	Homo sapiens	9	Protein			59306	CHEMBL1909046							499	CHEMBL3308370	MDCK		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801958	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774657	CHEMBL1909178	B	DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)	15	DrugMatrix	Rattus norvegicus		10116	Autocuration	BAO_0000221	11677	CHEMBL3048	SINGLE PROTEIN	P29476	Nitric-oxide synthase, brain	Rattus norvegicus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799792	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774707	CHEMBL1909096	B	DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A)	15	DrugMatrix			32644	Autocuration	BAO_0000219	10692	CHEMBL4607	SINGLE PROTEIN	P50052	Angiotensin II type 2 (AT-2) receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801969	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774663	CHEMBL1909184	B	DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP)	15	DrugMatrix	Homo sapiens		9606	Autocuration	BAO_0000221	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046							5578	CHEMBL3833781	Platelet		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801897	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774759	CHEMBL1909148	B	DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801921	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774771	CHEMBL1909160	B	DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	101214	CHEMBL5486	SINGLE PROTEIN	P15127	Insulin receptor	Rattus norvegicus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804098	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774726	CHEMBL1909115	B	DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone)	15	DrugMatrix	Escherichia coli		562	Autocuration	BAO_0000249	12832	CHEMBL3072	SINGLE PROTEIN	P15207	Androgen Receptor	Rattus norvegicus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801917	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774769	CHEMBL1909158	B	DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA)	15	DrugMatrix	Escherichia coli		562	Autocuration	BAO_0000357	24	CHEMBL402	SINGLE PROTEIN	P04035	HMG-CoA reductase	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799841	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774749	CHEMBL1909138	B	DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)	15	DrugMatrix			32644	Autocuration	BAO_0000219	17045	CHEMBL340	SINGLE PROTEIN	P08684	Cytochrome P450 3A4	Homo sapiens	9	Protein			59306	CHEMBL1909046							5579	CHEMBL3833782	BTI-TN-5B1-4		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804094	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774724	CHEMBL1909113	B	DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P)	15	DrugMatrix			32644	Autocuration	BAO_0000249	250	CHEMBL249	SINGLE PROTEIN	P25103	Neurokinin 1 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							449	CHEMBL3308072	CHO		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801997	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774677	CHEMBL1909198	B	DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone)	15	DrugMatrix			32644	Autocuration	BAO_0000219	11635	CHEMBL299	SINGLE PROTEIN	P17252	Protein kinase C alpha	Homo sapiens	9	Protein			59306	CHEMBL1909046							1759	CHEMBL3308860	Sf9		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799817	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774737	CHEMBL1909126	B	DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10580	CHEMBL274	SINGLE PROTEIN	P51681	C-C chemokine receptor type 5	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801929	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774643	CHEMBL1909164	B	DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4)	15	DrugMatrix			32644	Autocuration	BAO_0000249	179	CHEMBL1798	SINGLE PROTEIN	Q9Y271	Cysteinyl leukotriene receptor 1	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801941	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774649	CHEMBL1909170	B	DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	61	CHEMBL216	SINGLE PROTEIN	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801949	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774653	CHEMBL1909174	B	DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	215	CHEMBL2035	SINGLE PROTEIN	P08912	Muscarinic acetylcholine receptor M5	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2488350	IC50	=	200000	nM		IC50	=	200	uM		Outside typical range	0	BAO_0000190	UO_0000065	http://www.openphacts.org/units/Nanomolar	519687	CHEMBL950909	F	Antiproliferative activity against human EAhy926 cells	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	22221	CHEMBL3879801	NON-MOLECULAR		Placeholder for assays where the target is a tissue/organism etc		1	Non-molecular			45564	CHEMBL1143283	19103485	Bioorg. Med. Chem. Lett.	2009	19	3	878					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3233235	IC50	>	50000	nM		IC50	>	50	uM			0	BAO_0000190	UO_0000065	http://www.openphacts.org/units/Nanomolar	622768	CHEMBL1107707	A	Cytotoxicity against HUVEC by MTT assay	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	81057	CHEMBL613979	CELL-LINE		HUVEC	Homo sapiens	1	Non-molecular			49997	CHEMBL1153763	19394719	Eur. J. Med. Chem.	2009	44	9	3533	473	CHEMBL3307501	HUVEC		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	5080854	Vdss	=	.95	L.kg-1		Vdss	=	.95	L/kg			0	BAO_0003041	UO_0000197		688902	CHEMBL1614670	A	Volume of distribution at steady state in human after iv administration	1	Scientific Literature	Homo sapiens		9606	Expert	BAO_0000218	22224	CHEMBL612558	ADMET		ADMET		0	Unassigned			54149	CHEMBL1614632	18426954	Drug Metab. Dispos.	2008	36	7	1385					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1 (Thalidomide)	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	435713	Ratio	=	1.23	-		Ratio	=	1.23				0	BAO_0000179			159429	CHEMBL765779	B	Selective index (SI) which is the ratio of IC50 of Prostaglandin G/H synthase 1 / IC50 of Prostaglandin G/H synthase 1 was reported	1	Scientific Literature	Ovis aries		9940	Intermediate	BAO_0000357	17047	CHEMBL2949	SINGLE PROTEIN	P05979	Cyclooxygenase-1	Ovis aries	9	Protein			5412	CHEMBL1135264	11909713	Bioorg. Med. Chem. Lett.	2002	12	7	1043					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3106412	Activity	=	9	%		Activity	=	9	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	610470	CHEMBL1064324	F	Induction of apoptosis in human Jurkat T cells at 100 uM after 24 hrs by flow cytometry	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	81072	CHEMBL397	CELL-LINE		Jurkat	Homo sapiens	1	Non-molecular			49883	CHEMBL1159046	20034801	Bioorg. Med. Chem.	2010	18	2	650	503	CHEMBL3307526	Jurkat		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thl	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13460576	Activity	=	3.6	ug ml-1		Activity	=	3.6	ug ml-1			0	BAO_0000181	UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	984970	CHEMBL2433019	F	Immunomodulatory activity in BALB/c mouse splenocytes assessed as inhibition of LPS-induced nitric oxide production at 50 ug/ml after 72 hrs by Griess method relative to control	1	Scientific Literature	Mus musculus	BALB/c	10090	Autocuration	BAO_0000219	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			74939	CHEMBL2429842		Med Chem Res	2013			1	321	CHEMBL3307957	Splenocyte		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	(+/-)-1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2673357	Activity	=	92.2	%		Activity	=	92.2	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	575153	CHEMBL1035532	F	Cytotoxicity against human KB cells assessed as cell viability at 100 ug/ml after 72 hrs by MTT assay	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	81115	CHEMBL398	CELL-LINE		KB	Homo sapiens	1	Non-molecular			47527	CHEMBL1151853	19297157	Bioorg. Med. Chem. Lett.	2009	19	14	3973	324	CHEMBL3307959	KB 		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2474407	Activity	=	159	%		Activity	=	159	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	536021	CHEMBL990702	F	Antiproliferative activity against mouse Ehrlich ascites carcinoma cells implanted in Swiss albino mouse assessed as inhibition of Ki67 protein expression treated after 7 days post-tumor implantation at 1.25 mM/kg, sc for 5 days by immunohistochemical analysis	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000218	80830	CHEMBL614641	CELL-LINE		Ehrlich	Mus musculus	1	Non-molecular			44747	CHEMBL1151683	18951804	Bioorg. Med. Chem.	2008	16	22	9708	666	CHEMBL3307669	Ehrlich		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	363009	Inhibition	<	5	%		Inhibition	<	5	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	104024	CHEMBL709633	B	Inhibition of malate dehydrogenase (MDH) at 400 uM	1	Scientific Literature				Expert	BAO_0000357	11275	CHEMBL3560	SINGLE PROTEIN	P40925	Malate dehydrogenase cytoplasmic	Homo sapiens	8	Homologous protein			17239	CHEMBL1145124	14521410	J. Med. Chem.	2003	46	21	4477					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3364561	Inhibition	=	73.3	%		INH	=	73.3	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	642709	CHEMBL1177001	F	Antinociceptive activity in Swiss mouse assessed as inhibition of acetic acid-induced abdominal constrictions at 100 umol/kg, po administered 40 mins before acetic acid challenge measured for 25 mins relative to control	1	Scientific Literature	Mus musculus	Swiss	10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			51813	CHEMBL1177683	20598893	Bioorg. Med. Chem.	2010	18	14	5007					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7834134	HepSE_liver fatty	=	0	-		HepSE_liver fatty	=	0				0				774796	CHEMBL1909318	A	Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty	1	Scientific Literature				Autocuration	BAO_0000221	103956	CHEMBL1697861	PHENOTYPE		Hepatotoxicity		1	Non-molecular			59327	CHEMBL1909294	22194678	PLOS Computational Biology	2011	7	12	1					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	10 (Thalidomide)	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	778631	Amount of TNF-alpha	=	58	%		Amount of TNF-alpha	=	58	%			0		UO_0000187	http://qudt.org/vocab/unit#Percent	78449	CHEMBL689156	F	Tumor necrosis factor-alpha production in human leukemia cell line (HL-60) stimulated with 50 nM okadaic acid (OA), at 30 uMolar.	1	Scientific Literature	Homo sapiens		9606	Expert	BAO_0000219	80156	CHEMBL383	CELL-LINE		HL-60	Homo sapiens	1	Non-molecular			14079	CHEMBL1130136	9288167	J. Med. Chem.	1997	40	18	2858	649	CHEMBL3307654	HL-60		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7834128	HepSE_hepatic failure	=	0	-		HepSE_hepatic failure	=	0				0				774790	CHEMBL1909312	A	Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure	1	Scientific Literature				Autocuration	BAO_0000221	103956	CHEMBL1697861	PHENOTYPE		Hepatotoxicity		1	Non-molecular			59327	CHEMBL1909294	22194678	PLOS Computational Biology	2011	7	12	1					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13981534	Hepatotoxicity (animal toxicity known)					Hepatotoxicity (animal toxicity known)					Potential missing data	0				1301389	CHEMBL3137736	T	Animal toxicity known. [column 'TOXIC' in source]	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000019	22221	CHEMBL3879801	NON-MOLECULAR		Placeholder for assays where the target is a tissue/organism etc		1	Non-molecular			77450	CHEMBL3137667	15646539	Gastroenterol Clin Biol	2004	28	8-9	720					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13981535	Hepatotoxicity (successful reintroduction)					Hepatotoxicity (successful reintroduction)					Potential missing data	0				1301390	CHEMBL3137737	T	Presence of at least one case with successful reintroduction. [column 'REINT' in source]	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			77450	CHEMBL3137667	15646539	Gastroenterol Clin Biol	2004	28	8-9	720					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2373843	Activity					Activity				Active		0	BAO_0000375			535239	CHEMBL981698	F	Reduction in iNOS expression in LPS-activated mouse RAW264.7 cells at 1 uM pretreated for 3 hrs before LPS challenge assessed after 24 hrs by Western blot	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000219	80418	CHEMBL612557	CELL-LINE		RAW264.7	Mus musculus	1	Non-molecular			44554	CHEMBL1144167	18723357	Bioorg. Med. Chem.	2008	16	18	8619	343	CHEMBL3307977	RAW264.7		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2474419	Activity					Activity				Active		0	BAO_0000375			536018	CHEMBL990699	A	Toxicity in Swiss albino mouse bearing mouse Ehrlich ascites carcinoma cells assessed as focal necrosis of hepatocytes treated after 7 days post-tumor implantation at 1.25 mM/kg, sc for 5 days by histopathological analysis	1	Scientific Literature	Mus musculus	Swiss albino	10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			44747	CHEMBL1151683	18951804	Bioorg. Med. Chem.	2008	16	22	9708	666	CHEMBL3307669	Ehrlich		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thl	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15619592	Inhibition					INH				Active		0	BAO_0000376			1498233	CHEMBL3583656	F	Inhibition of IL-1beta production in LPS-induced mouse peritoneal macrophages at 50 uM incubated for 24 hrs by sandwich ELISA method	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000219	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			92436	CHEMBL3580609		MedChemComm	2014	5	6	758	421	CHEMBL3308045	Peritoneal macrophage cell		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID170465323	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15472064	AC50		1420	nM		AC50		1.42	uM	inactive		0	BAO_0000186	UO_0000065	http://www.openphacts.org/units/Nanomolar	1495242	CHEMBL3561973	F	PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 1 ratio channel.   (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID170465323	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15583839	Ac50		.631	uM		Ac50		.630957345	uM	inactive		0	BAO_0000186	UO_0000064	http://www.openphacts.org/units/Micromolar	1495333	CHEMBL3562064	F	PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, blue channel.   (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID170465323	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15553268	Ac50		39.81	uM		Ac50		39.81071706	uM	inactive		0	BAO_0000186	UO_0000064	http://www.openphacts.org/units/Micromolar	1495259	CHEMBL3561990	F	PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus: Screen 2, green channel.   (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	9087515	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809079	CHEMBL1964065	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SR Leukemia cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	81325	CHEMBL614300	CELL-LINE		SR	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							572	CHEMBL3307586	SR		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8838074	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809057	CHEMBL1964043	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-62 Non-Small Cell Lung cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	81201	CHEMBL614643	CELL-LINE		HOP-62	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							668	CHEMBL3307671	HOP-62		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8500932	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809024	CHEMBL1963991	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80972	CHEMBL613889	CELL-LINE		HOP-92	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							469	CHEMBL3308091	HOP-92		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	9827339	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809314	CHEMBL1963866	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SNB-75 Central Nervous System cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	81278	CHEMBL614451	CELL-LINE		SNB-75	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							606	CHEMBL3307616	SNB-75		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	9484225	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809105	CHEMBL1964091	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the OVCAR-4 Ovarian cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80355	CHEMBL614051	CELL-LINE		OVCAR-4	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							493	CHEMBL3307517	OVCAR-4		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	9260236	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809089	CHEMBL1964075	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H522 Non-Small Cell Lung cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	81283	CHEMBL614387	CELL-LINE		NCI-H522	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							600	CHEMBL3308392	NCI-H522		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	9407598	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809102	CHEMBL1964088	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the RPMI-8226 Leukemia cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80433	CHEMBL614882	CELL-LINE		RPMI-8226	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							741	CHEMBL3307732	RPMI-8226		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID26751823	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	6958527	Potency		1.1	nM		Potency		.0011	uM	inconclusive		0	BAO_0000186	UO_0000065	http://www.openphacts.org/units/Nanomolar	752571	CHEMBL1794561	F	PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000019	271	CHEMBL1947	SINGLE PROTEIN	P10828	Thyroid hormone receptor beta-1	Homo sapiens	9	Protein			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13981536	Hepatotoxicity (comment)					Hepatotoxicity (comment)				REACTIVATION_HVC		0				1301391	CHEMBL3137738	T	Comments (NB not yet translated). [column 'COMMENTAIRES' in source]	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			77450	CHEMBL3137667	15646539	Gastroenterol Clin Biol	2004	28	8-9	720					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13981533	Hepatotoxicity (benign tumour)	=	0	-		Hepatotoxicity (benign tumour)	=	0		references out of a total of 5		0				1301388	CHEMBL3137735	T	Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000019	22221	CHEMBL3879801	NON-MOLECULAR		Placeholder for assays where the target is a tissue/organism etc		1	Non-molecular			77450	CHEMBL3137667	15646539	Gastroenterol Clin Biol	2004	28	8-9	720					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346610	ALP	=	276	U.L-1		ALKALINE PHOSPHATASE	=	276	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = ALP (Alkaline Phosphatase) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345571	AST	=	62.83	U.L-1		ASPARTATE AMINOTRANSFERASE	=	62.83	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = AST (Aspartate Aminotransferase) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345774	BUN	=	166.7	ug.mL-1		BLOOD UREA NITROGEN	=	16.67	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BUN (Blood Urea Nitrogen) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345872	HCT	=	44.35	%		HEMATOCRIT	=	44.35	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HCT (Hematocrit) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346686	MCH	=	19.7	pg		MEAN CORPUSCULAR HEMOGLOBIN	=	19.7	PG	See Activity_Supp For Individual Animal Data		0		UO_0000025		1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MCH (Ery. Mean Corpuscular Hemoglobin) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346632	MCV	=	62.73	fL		MEAN CORPUSCULAR VOLUME	=	62.73	FL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MCV (Ery. Mean Corpuscular Volume) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345914	MCV	=	63.72	fL		MEAN CORPUSCULAR VOLUME	=	63.72	FL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MCV (Ery. Mean Corpuscular Volume) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345718	MCV	=	64.22	fL		MEAN CORPUSCULAR VOLUME	=	64.22	FL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MCV (Ery. Mean Corpuscular Volume) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346649	BILI	=	3	ug.mL-1		TOTAL BILIRUBIN	=	.3	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BILI (Bilirubin) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345613	GLUC	=	1826.7	ug.mL-1		GLUCOSE	=	182.67	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = GLUC (Glucose) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346631	MCHC	=	310300	ug.mL-1		MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION	=	31.03	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MCHC (Ery. Mean Corpuscular HGB Concentration) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345907	MCHC	=	315200	ug.mL-1		MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION	=	31.52	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MCHC (Ery. Mean Corpuscular HGB Concentration) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346715	MCHC	=	319000	ug.mL-1		MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION	=	31.9	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MCHC (Ery. Mean Corpuscular HGB Concentration) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345739	PLAT	=	1217170	cells.uL-1		PLATELET COUNT	=	1217.17	x10E3/uL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PLAT (Platelets) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346678	PROT	=	66000	ug.mL-1		TOTAL PROTEIN	=	6.6	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PROT (Protein) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346672	CREAT	=	5.7	ug.mL-1		CREATININE	=	.57	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CREAT (Creatinine) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346633	MONOLE	=	2.13	%		MONOCYTE	=	2.13	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MONOLE (Monocytes/Leukocytes) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345921	MONOLE	=	2.37	%		MONOCYTE	=	2.37	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MONOLE (Monocytes/Leukocytes) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345928	NEUTLE	=	14.05	%		NEUTROPHIL	=	14.05	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = NEUTLE (Neutrophils/Leukocytes) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345732	NEUTLE	=	18.6	%		NEUTROPHIL	=	18.6	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = NEUTLE (Neutrophils/Leukocytes) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346697	CHLORIDE	=	101	mEq.L-1		CHLORIDE	=	101	MEQ/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CHLORIDE (Chloride) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483271	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = NUCLEAR CYTOPLASMIC CONDENSATION | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483281	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CENTRILOBULAR, INFLAMMATORY CELL INFILTRATE, LYMPHOID | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483283	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CLEAR CELL FOCUS | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483291	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, CENTRILOBULAR, NECROSIS, APOPTOTIC | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483301	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, NONZONAL, GLYCOGEN ACCUMULATION | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483302	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, NONZONAL, INCREASED MITOSES | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483305	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, NONZONAL, MINERALIZATION | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483309	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, PERIPORTAL, CYTOPLASM, EOSINOPHILIA | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483325	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PERIPORTAL, FIBROSIS | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483326	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PERIPORTAL, INFLAMMATORY CELL INFILTRATE, LYMPHOID | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483327	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PERIPORTAL, INFLAMMATORY CELL INFILTRATE, MIXED CELL | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483329	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = SUBCAPSULAR, FIBROSIS | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801982	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774669	CHEMBL1909190	B	DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole)	15	DrugMatrix			32644	Autocuration	BAO_0000249	165	CHEMBL240	SINGLE PROTEIN	Q12809	HERG	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801980	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774668	CHEMBL1909189	B	DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide)	15	DrugMatrix			32644	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804093	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774723	CHEMBL1909112	B	DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799796	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774709	CHEMBL1909098	B	DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat))	15	DrugMatrix	Cavia porcellus	Dunkin-Hartley	10141	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799806	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774714	CHEMBL1909103	B	DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802000	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774678	CHEMBL1909199	B	DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)	15	DrugMatrix	Escherichia coli		562	Autocuration	BAO_0000357	11639	CHEMBL3385	SINGLE PROTEIN	P27361	MAP kinase ERK1	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799826	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774741	CHEMBL1909130	B	DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid)	15	DrugMatrix	Homo sapiens		9606	Autocuration	BAO_0000221	96	CHEMBL221	SINGLE PROTEIN	P23219	Cyclooxygenase-1	Homo sapiens	9	Protein			59306	CHEMBL1909046							5578	CHEMBL3833781	Platelet		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801992	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774674	CHEMBL1909195	B	DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)	15	DrugMatrix	Homo sapiens		9606	Autocuration	BAO_0000221	235	CHEMBL248	SINGLE PROTEIN	P08246	Leukocyte elastase	Homo sapiens	9	Protein			59306	CHEMBL1909046							428	CHEMBL3308052	Neutrophil		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799830	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774743	CHEMBL1909132	B	DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)	15	DrugMatrix			32644	Autocuration	BAO_0000219	12594	CHEMBL3356	SINGLE PROTEIN	P05177	Cytochrome P450 1A2	Homo sapiens	9	Protein			59306	CHEMBL1909046							5579	CHEMBL3833782	BTI-TN-5B1-4		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799834	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774745	CHEMBL1909134	B	DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)	15	DrugMatrix			32644	Autocuration	BAO_0000219	12912	CHEMBL3622	SINGLE PROTEIN	P33261	Cytochrome P450 2C19	Homo sapiens	9	Protein			59306	CHEMBL1909046							5579	CHEMBL3833782	BTI-TN-5B1-4		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799850	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774753	CHEMBL1909142	B	DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone)	15	DrugMatrix			32644	Autocuration	BAO_0000249	90	CHEMBL219	SINGLE PROTEIN	P21917	Dopamine D4 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801962	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774659	CHEMBL1909180	B	DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)	15	DrugMatrix			32644	Autocuration	BAO_0000249	136	CHEMBL236	SINGLE PROTEIN	P41143	Delta opioid receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804089	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774721	CHEMBL1909110	B	DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol)	15	DrugMatrix			32644	Autocuration	BAO_0000249	11272	CHEMBL287	SINGLE PROTEIN	Q99720	Sigma opioid receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							503	CHEMBL3307526	Jurkat		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801928	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774642	CHEMBL1909163	B	DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4)	15	DrugMatrix	Cavia porcellus		10141	Autocuration	BAO_0000221	104321	CHEMBL1909043	SINGLE PROTEIN	A6XA80	Leukotriene C4 synthase	Cavia porcellus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799784	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774703	CHEMBL1909092	B	DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177)	15	DrugMatrix			32644	Autocuration	BAO_0000249	43	CHEMBL210	SINGLE PROTEIN	P07550	Beta-2 adrenergic receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							449	CHEMBL3308072	CHO		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802014	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774685	CHEMBL1909206	B	DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))	15	DrugMatrix			32644	Autocuration	BAO_0000219	10140	CHEMBL258	SINGLE PROTEIN	P06239	Tyrosine-protein kinase LCK	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804083	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774718	CHEMBL1909107	B	DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808)	15	DrugMatrix	Cavia porcellus	Dunkin-Hartley	10141	Autocuration	BAO_0000249	20033	CHEMBL5017	SINGLE PROTEIN	O70528	Serotonin 4 (5-HT4) receptor	Cavia porcellus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801954	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774655	CHEMBL1909176	B	DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10477	CHEMBL4018	SINGLE PROTEIN	P49146	Neuropeptide Y receptor type 2	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801930	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774643	CHEMBL1909164	B	DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4)	15	DrugMatrix			32644	Autocuration	BAO_0000249	179	CHEMBL1798	SINGLE PROTEIN	Q9Y271	Cysteinyl leukotriene receptor 1	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801942	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774649	CHEMBL1909170	B	DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	61	CHEMBL216	SINGLE PROTEIN	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802008	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774682	CHEMBL1909203	B	DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))	15	DrugMatrix			32644	Autocuration	BAO_0000219	9	CHEMBL203	SINGLE PROTEIN	P00533	Epidermal growth factor receptor erbB1	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802012	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774684	CHEMBL1909205	B	DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))	15	DrugMatrix			32644	Autocuration	BAO_0000219	188	CHEMBL1824	SINGLE PROTEIN	P04626	Receptor protein-tyrosine kinase erbB-2	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799793	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774708	CHEMBL1909097	B	DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)	15	DrugMatrix	Sus scrofa		9823	Autocuration	BAO_0000221	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801971	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774664	CHEMBL1909185	B	DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP)	15	DrugMatrix			32644	Autocuration	BAO_0000219	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046							379	CHEMBL3308006	U-937		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804092	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774723	CHEMBL1909112	B	DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802017	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774687	CHEMBL1909208	B	DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)	15	DrugMatrix	Oryctolagus cuniculus	New Zealand albino	9986	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799805	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774714	CHEMBL1909103	B	DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799759	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774691	CHEMBL1909212	B	DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine)	15	DrugMatrix			32644	Autocuration	BAO_0000219	93	CHEMBL220	SINGLE PROTEIN	P22303	Acetylcholinesterase	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801915	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774768	CHEMBL1909157	B	DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	102	CHEMBL1941	SINGLE PROTEIN	P25021	Histamine H2 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804096	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774725	CHEMBL1909114	B	DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10184	CHEMBL2327	SINGLE PROTEIN	P21452	Neurokinin 2 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							449	CHEMBL3308072	CHO		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802015	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774686	CHEMBL1909207	B	DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)	15	DrugMatrix	Escherichia coli		562	Autocuration	BAO_0000357	12088	CHEMBL3243	SINGLE PROTEIN	P08575	Leukocyte common antigen	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799781	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774702	CHEMBL1909091	B	DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol)	15	DrugMatrix			32644	Autocuration	BAO_0000249	50	CHEMBL213	SINGLE PROTEIN	P08588	Beta-1 adrenergic receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801931	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774644	CHEMBL1909165	B	DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid)	15	DrugMatrix	Oryctolagus cuniculus		9986	Autocuration	BAO_0000221	20075	CHEMBL4358	SINGLE PROTEIN	P12530	Arachidonate 15-lipoxygenase	Oryctolagus cuniculus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801985	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774671	CHEMBL1909192	B	DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)	15	DrugMatrix	Oryctolagus cuniculus		9986	Autocuration	BAO_0000221	10438	CHEMBL4074	SINGLE PROTEIN	P12822	Angiotensin-converting enzyme	Oryctolagus cuniculus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799813	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774735	CHEMBL1909124	B	DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1)	15	DrugMatrix			32644	Autocuration	BAO_0000249	11575	CHEMBL4015	SINGLE PROTEIN	P41597	C-C chemokine receptor type 2	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802019	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774688	CHEMBL1909209	B	DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10576	CHEMBL273	SINGLE PROTEIN	P19327	Serotonin 1a (5-HT1a) receptor	Rattus norvegicus	8	Homologous protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801975	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774666	CHEMBL1909187	B	DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF)	15	DrugMatrix	Homo sapiens		9606	Autocuration	BAO_0000221	251	CHEMBL250	SINGLE PROTEIN	P25105	Platelet activating factor receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							5578	CHEMBL3833781	Platelet		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801943	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774650	CHEMBL1909171	B	DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	47	CHEMBL211	SINGLE PROTEIN	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801947	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774652	CHEMBL1909173	B	DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	214	CHEMBL1821	SINGLE PROTEIN	P08173	Muscarinic acetylcholine receptor M4	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	16469730	Ki	=	16100	nM	4.79	Ki	=	16.1	uM			0	BAO_0000192	UO_0000065	http://www.openphacts.org/units/Nanomolar	1555521	CHEMBL3768103	B	Inhibition of MANT-uracil binding to Caenorhabditis elegans CRBN (delta 1 to 15) by Cheng-Prusoff equation analysis	1	Scientific Literature	Caenorhabditis elegans		6239	Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			98322	CHEMBL3763149	26730808	J. Med. Chem.	2016	59	2	770					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	16469729	Ki	=	22700	nM	4.64	Ki	=	22.7	uM			0	BAO_0000192	UO_0000065	http://www.openphacts.org/units/Nanomolar	1555520	CHEMBL3768102	B	Inhibition of MANT-uracil binding to human CRBN (delta 1 to 315) by Cheng-Prusoff equation analysis	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000357	116734	CHEMBL3763008	SINGLE PROTEIN	Q96SW2	Protein cereblon	Homo sapiens	9	Protein			98322	CHEMBL3763149	26730808	J. Med. Chem.	2016	59	2	770					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	16469725	IC50	=	29900	nM	4.52	IC50	=	29.9	uM			0	BAO_0000190	UO_0000065	http://www.openphacts.org/units/Nanomolar	1555516	CHEMBL3768098	B	Inhibition of MANT-uracil binding to human CRBN (delta 1 to 315) by FRET assay	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000357	116734	CHEMBL3763008	SINGLE PROTEIN	Q96SW2	Protein cereblon	Homo sapiens	9	Protein			98322	CHEMBL3763149	26730808	J. Med. Chem.	2016	59	2	770					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thal	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8045393	IC50	>	400000	nM		IC50	>	400	uM		Outside typical range	0	BAO_0000190	UO_0000065	http://www.openphacts.org/units/Nanomolar	806525	CHEMBL1959658	A	Cytotoxicity against mouse J744 cells after 48 hrs by MTT assay	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000219	22224	CHEMBL612558	ADMET		ADMET		0	Unassigned			61309	CHEMBL1955718	22356737	Bioorg. Med. Chem.	2012	20	6	2158					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thl	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15620249	Activity	=	2	%		Activity	=	2	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	1498240	CHEMBL3583663	A	Induction of total cell death in human Jurkat cells containing GFP gene under control of TNF gene promoter at 100 uM incubated for 24 hrs by propidium iodide staining based assay	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	81072	CHEMBL397	CELL-LINE		Jurkat	Homo sapiens	1	Non-molecular			92436	CHEMBL3580609		MedChemComm	2014	5	6	758	503	CHEMBL3307526	Jurkat		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3233120	Activity	=	53	%		Activity	=	53	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	622765	CHEMBL1107704	F	Enhancement of 12-O-tetradecanoylphorbol-13-acetate-induced TNFalpha production in human HL60 cell at 30 uM after 16 hrs by ELISA relative to control	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	80156	CHEMBL383	CELL-LINE		HL-60	Homo sapiens	1	Non-molecular			49997	CHEMBL1153763	19394719	Eur. J. Med. Chem.	2009	44	9	3533	649	CHEMBL3307654	HL-60		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	(+/-)-1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2673369	Activity	=	107	%		Activity	=	107	%			0	BAO_0001103	UO_0000187	http://qudt.org/vocab/unit#Percent	575155	CHEMBL1035534	F	Cytotoxicity against human IM9 cells assessed as cell viability at 100 ug/ml after 72 hrs by MTT assay	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	80174	CHEMBL614584	CELL-LINE		IM-9	Homo sapiens	1	Non-molecular			47527	CHEMBL1151853	19297157	Bioorg. Med. Chem. Lett.	2009	19	14	3973	198	CHEMBL3307412	IM-9		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15035790	Activity	=	4600000	-		Activity	=	4600000				0	BAO_0000181			1456290	CHEMBL3367813	F	Antimycobacterial activity against Mycobacterium leprae inoculated in mouse model assessed as mean number of bacilli at 200 mg/kg, po 5 days/week for 4 weeks (Rvb = 3.56 x 10'6 cells)	1	Scientific Literature	Mycobacterium leprae		1769	Autocuration	BAO_0000218	108423	CHEMBL3301409	ORGANISM		Mycobacterium leprae	Mycobacterium leprae	1	Non-molecular			90230	CHEMBL3352176	24907144	Bioorg. Med. Chem. Lett.	2014	24	14	3084					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2474371	Activity	=	108.4	U		Activity	=	108.4	U			0	BAO_0000181			536012	CHEMBL990693	F	Increase in SOD activity per gram of tissue in mouse Ehrlich ascites carcinoma cells implanted in Swiss albino mouse treated after 7 days post-tumor implantation at 1.25 mM/kg, sc for 5 days	1	Scientific Literature	Mus musculus	Swiss albino	10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			44747	CHEMBL1151683	18951804	Bioorg. Med. Chem.	2008	16	22	9708	666	CHEMBL3307669	Ehrlich		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	3106355	Inhibition	=	6	%		INH	=	6	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	610459	CHEMBL1064313	B	Inhibition of NF-kappaB-mediated TNF expression in human Jurkat T cells coexpressing GFP reporter gene at 100 uM by flow cytometry	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			49883	CHEMBL1159046	20034801	Bioorg. Med. Chem.	2010	18	2	650	503	CHEMBL3307526	Jurkat		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thal	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8045417	Inhibition	=	57	%		INH	=	57	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	806521	CHEMBL1959654	B	Inhibition of NF-kappaB activation expressed in human HT-29 cells assessed as inhibition of TNFalpha-stimulated IL8 release at 400 uM after 24 hrs by flow cytometric analysis relative to control	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			61309	CHEMBL1955718	22356737	Bioorg. Med. Chem.	2012	20	6	2158	786	CHEMBL3307768	HT-29		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thal	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8045483	Inhibition	=	116	%		INH	=	116	%			0	BAO_0000201	UO_0000187	http://qudt.org/vocab/unit#Percent	806384	CHEMBL1959226	B	Inhibition of TNFalpha-induced NF-kappaB activation expressed in human HT-29 cells coexpressing hrGFP at 400 uM after 24 hrs by propidium iodide staining-based flow cytometric analysis relative to control	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000219	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			61309	CHEMBL1955718	22356737	Bioorg. Med. Chem.	2012	20	6	2158	786	CHEMBL3307768	HT-29		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	1, Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2474413	Activity					Activity				Active		0	BAO_0000375			536015	CHEMBL990696	A	Toxicity in Swiss albino mouse bearing mouse Ehrlich ascites carcinoma cells assessed as focal degeneration of hepatocytes treated after 7 days post-tumor implantation at 1.25 mM/kg, sc for 5 days by histopathological analysis	1	Scientific Literature	Mus musculus	Swiss albino	10090	Autocuration	BAO_0000218	50594	CHEMBL375	ORGANISM		Mus musculus	Mus musculus	1	Non-molecular			44747	CHEMBL1151683	18951804	Bioorg. Med. Chem.	2008	16	22	9708	666	CHEMBL3307669	Ehrlich		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID170465323	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	15594578	AC50		631	nM		AC50		.631	uM	inactive		0	BAO_0000186	UO_0000065	http://www.openphacts.org/units/Nanomolar	1495405	CHEMBL3562136	F	PubChem BioAssay. qHTS Assay for Identifying Compounds that block Entry of Ebola Virus, Screen 2 blue channel.   (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	10095239	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809333	CHEMBL1963885	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the PC-3 Prostate cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80390	CHEMBL390	CELL-LINE		PC-3	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							555	CHEMBL3307570	PC-3		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	10131783	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809348	CHEMBL1963900	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the T-47D Breast cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80712	CHEMBL614361	CELL-LINE		T47D	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							594	CHEMBL3307606	T47D		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8237928	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809014	CHEMBL1963981	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80498	CHEMBL614054	CELL-LINE		SN12C	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							494	CHEMBL3307518	SN12C		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8830966	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809054	CHEMBL1964040	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MOLT-4 Leukemia cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80285	CHEMBL614177	CELL-LINE		MOLT-4	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							537	CHEMBL3307557	MOLT-4		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	10450094	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809393	CHEMBL1963945	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HS 578T Breast cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80991	CHEMBL614645	CELL-LINE		Hs-578T	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							669	CHEMBL3307672	Hs-578T		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	10571243	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809409	CHEMBL1963961	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the CCRF-CEM Leukemia cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80064	CHEMBL382	CELL-LINE		CCRF-CEM	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							635	CHEMBL3307641	CCRF-CEM		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	10781723	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809431	CHEMBL1964012	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the COLO 205 Colon cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80099	CHEMBL614561	CELL-LINE		COLO 205	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							641	CHEMBL3308348	COLO 205		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8624840	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809039	CHEMBL1964025	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	81248	CHEMBL614021	CELL-LINE		Malme-3M	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							480	CHEMBL3307507	Malme-3M		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	8622221	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809035	CHEMBL1964021	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80488	CHEMBL614922	CELL-LINE		SK-MEL-5	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							755	CHEMBL3307744	SK-MEL-5		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID111716	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	9405277	GI50		100000	nM		log GI50 (M)		-4		inactive		0				809101	CHEMBL1964087	F	PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H322M Non-Small Cell Lung cell line. (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000219	80889	CHEMBL614803	CELL-LINE		NCI-H322M	Homo sapiens	1	Non-molecular			51887	CHEMBL1201862							715	CHEMBL3307710	NCI-H322M		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	SID26747126	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	14348362	Potency		125892.5	nM		Potency		125.8925	uM	inactive		0	BAO_0000186	UO_0000065	http://www.openphacts.org/units/Nanomolar	688671	CHEMBL1614211	F	PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) 	7	PubChem BioAssays				Autocuration	BAO_0000019	101476	CHEMBL5619	SINGLE PROTEIN	P27695	DNA-(apurinic or apyrimidinic site) lyase	Homo sapiens	9	Protein			51887	CHEMBL1201862											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	2373846	Activity					Activity				Dose-dependent effect		0	BAO_0000375			535234	CHEMBL991731	F	Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production pretreated for 3 hrs before LPS challenge assessed after 24 hrs by griess assay	1	Scientific Literature	Mus musculus		10090	Autocuration	BAO_0000219	80418	CHEMBL612557	CELL-LINE		RAW264.7	Mus musculus	1	Non-molecular			44554	CHEMBL1144167	18723357	Bioorg. Med. Chem.	2008	16	18	8619	343	CHEMBL3307977	RAW264.7		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13981524	Hepatotoxicity (cytolytic)	=	2	-		Hepatotoxicity (cytolytic)	=	2		references out of a total of 5		0				1301379	CHEMBL3137726	T	Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000221	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			77450	CHEMBL3137667	15646539	Gastroenterol Clin Biol	2004	28	8-9	720					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13981526	Hepatotoxicity (severe hepatitis)	=	0	-		Hepatotoxicity (severe hepatitis)	=	0		references out of a total of 5		0				1301381	CHEMBL3137728	T	Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000221	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			77450	CHEMBL3137667	15646539	Gastroenterol Clin Biol	2004	28	8-9	720					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	13981530	Hepatotoxicity (association with vascular disease)	=	0	-		Hepatotoxicity (association with vascular disease)	=	0		references out of a total of 5		0				1301385	CHEMBL3137732	T	Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]	1	Scientific Literature	Homo sapiens		9606	Autocuration	BAO_0000019	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			77450	CHEMBL3137667	15646539	Gastroenterol Clin Biol	2004	28	8-9	720					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	Thalidomide	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	5319792	Hepatotoxicity					Hepatotoxicity				no drug-induced liver injury reported		0				736786	CHEMBL1697780	A	Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents	1	Scientific Literature				Autocuration	BAO_0000221	103956	CHEMBL1697861	PHENOTYPE		Hepatotoxicity		1	Non-molecular			56111	CHEMBL1697731	20014752	Chem. Res. Toxicol.	2010	23	1	171					
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346638	ALP	=	320	U.L-1		ALKALINE PHOSPHATASE	=	320	u/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = ALP (Alkaline Phosphatase) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346612	BUN	=	110	ug.mL-1		BLOOD UREA NITROGEN	=	11	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BUN (Blood Urea Nitrogen) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345900	MCH	=	20.1	pg		MEAN CORPUSCULAR HEMOGLOBIN	=	20.1	PG	See Activity_Supp For Individual Animal Data		0		UO_0000025		1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MCH (Ery. Mean Corpuscular Hemoglobin) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346688	MCV	=	62.43	fL		MEAN CORPUSCULAR VOLUME	=	62.43	FL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MCV (Ery. Mean Corpuscular Volume) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345865	RBC	=	6960000	cells.uL-1		ERYTHROCYTE COUNT	=	6.96	x10E6/uL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = RBC (Erythrocytes) | DATASET = Hematology | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345837	BILI	=	5.3	ug.mL-1		TOTAL BILIRUBIN	=	.53	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BILI (Bilirubin) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345788	CHOL	=	663.3	ug.mL-1		CHOLESTEROL	=	66.33	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CHOL (Cholesterol) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346659	MCHC	=	317000	ug.mL-1		MEAN CORPUSCULAR HEMOGLOBIN CONCENTRATION	=	31.7	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = MCHC (Ery. Mean Corpuscular HGB Concentration) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346646	PHOS	=	119.3	ug.mL-1		PHOSPHORUS	=	11.93	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PHOS (Phosphate) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346618	PHOS	=	127.7	ug.mL-1		PHOSPHORUS	=	12.77	mg/dL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PHOS (Phosphate) | DATASET = Biochemistry | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346635	PLAT	=	1452670	cells.uL-1		PLATELET COUNT	=	1452.67	x10E3/uL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PLAT (Platelets) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346663	PLAT	=	1535330	cells.uL-1		PLATELET COUNT	=	1535.33	x10E3/uL	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PLAT (Platelets) | DATASET = Hematology | DOSE = 3 mg/Kg | DOSE_LEVEL = Low | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17345844	PROT	=	67700	ug.mL-1		TOTAL PROTEIN	=	6.77	G/DL	See Activity_Supp For Individual Animal Data		0		UO_0000274	http://www.openphacts.org/units/MicrogramPerMilliliter	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = PROT (Protein) | DATASET = Biochemistry | DOSE = 0 mg/Kg | DOSE_LEVEL = Control | N_ANIMALS = 6  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346685	LYMLE	=	80	%		LYMPHOCYTE	=	80	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = LYMLE (Lymphocytes/Leukocytes) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346713	LYMLE	=	79.9	%		LYMPHOCYTE	=	79.9	%	See Activity_Supp For Individual Animal Data		0		UO_0000187	http://qudt.org/vocab/unit#Percent	1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = LYMLE (Lymphocytes/Leukocytes) | DATASET = Hematology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Blood | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346704	SODIUM	=	147	mEq.L-1		SODIUM	=	147	MEQ/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = SODIUM (Sodium) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346703	POTASSIUM	=	5.8	mEq.L-1		POTASSIUM	=	5.8	MEQ/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = POTASSIUM (Potassium) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17346675	POTASSIUM	=	6.2	mEq.L-1		POTASSIUM	=	6.2	MEQ/L	See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = POTASSIUM (Potassium) | DATASET = Biochemistry | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 72 hr | TISSUE = Plasma | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483275	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = BILE DUCT HYPERPLASIA | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483279	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = CAPSULE, THROMBUS | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483294	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, DIFFUSE, HYPERTROPHY | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483298	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, MIDZONAL, NECROSIS, ONCOCYTIC | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483306	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, NONZONAL, MULTINUCLEATED | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483311	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = HEPATOCYTE, PERIPORTAL, HYPERTROPHY | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	17483319	Tissue Severity Score					Tissue Severity Score				See Activity_Supp For Individual Animal Data		0				1640282	CHEMBL3885882	T	DrugMatrix - Regimen: Daily Repeat	15	DrugMatrix	Rattus norvegicus	Sprague-Dawley	10116	Autocuration	BAO_0000218	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			102506	CHEMBL3885881										ACTIVITY_TEST = NONZONAL, EXTRAMEDULLARY HEMATOPOIESIS | DATASET = Pathology | DOSE = 113 mg/Kg | DOSE_LEVEL = High | N_ANIMALS = 3  | ROUTE = ORAL GAVAGE | SRC_ACTIVITY_ID = 70  | TIME = 120 hr | TISSUE = LIVER | TOXICOLOGY_STUDY_DATE = 20021008 | TOXICOLOGY_STUDY_ID = R021008 | TOXICOLOGY_STUDY_LAB = Ricera | VEHICLE = .5 % CMC	
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801904	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774762	CHEMBL1909151	B	DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801920	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774770	CHEMBL1909159	B	DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801908	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774764	CHEMBL1909153	B	DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799802	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774712	CHEMBL1909101	B	DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon))	15	DrugMatrix			32644	Autocuration	BAO_0000249	119	CHEMBL1832	SINGLE PROTEIN	P30988	Calcitonin receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							594	CHEMBL3307606	T47D		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799848	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774752	CHEMBL1909141	B	DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone)	15	DrugMatrix			32644	Autocuration	BAO_0000249	130	CHEMBL234	SINGLE PROTEIN	P35462	Dopamine D3 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							449	CHEMBL3308072	CHO		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799812	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774734	CHEMBL1909123	B	DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA))	15	DrugMatrix	Homo sapiens		9606	Autocuration	BAO_0000221	15	CHEMBL205	SINGLE PROTEIN	P00918	Carbonic anhydrase II	Homo sapiens	9	Protein			59306	CHEMBL1909046							5555	CHEMBL3833281	Erythrocyte		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804095	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774724	CHEMBL1909113	B	DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P)	15	DrugMatrix			32644	Autocuration	BAO_0000249	250	CHEMBL249	SINGLE PROTEIN	P25103	Neurokinin 1 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							449	CHEMBL3308072	CHO		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801984	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774670	CHEMBL1909191	B	DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020)	15	DrugMatrix	Bos taurus		9913	Autocuration	BAO_0000221	104322	CHEMBL1909044	SINGLE PROTEIN	Q690N0	Progesterone receptor	Bos taurus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799764	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774693	CHEMBL1909214	B	DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA)	15	DrugMatrix			32644	Autocuration	BAO_0000249	252	CHEMBL251	SINGLE PROTEIN	P29274	Adenosine A2a receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801902	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774761	CHEMBL1909150	B	DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone)	15	DrugMatrix			32644	Autocuration	BAO_0000219	25	CHEMBL2034	SINGLE PROTEIN	P04150	Glucocorticoid receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							5587	CHEMBL3886002	HeLa S3		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801934	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774645	CHEMBL1909166	B	DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH)	15	DrugMatrix			32644	Autocuration	BAO_0000249	11003	CHEMBL4644	SINGLE PROTEIN	P41968	Melanocortin receptor 3	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804109	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774731	CHEMBL1909120	B	DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr)	15	DrugMatrix			32644	Autocuration	BAO_0000249	134	CHEMBL1889	SINGLE PROTEIN	P37288	Vasopressin V1a receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799774	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774698	CHEMBL1909087	B	DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin)	15	DrugMatrix			32644	Autocuration	BAO_0000249	103	CHEMBL223	SINGLE PROTEIN	P25100	Alpha-1d adrenergic receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							722	CHEMBL3307715	HEK293		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804085	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774719	CHEMBL1909108	B	DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10627	CHEMBL3371	SINGLE PROTEIN	P50406	Serotonin 6 (5-HT6) receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							308	CHEMBL3308376	HeLa		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801986	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774671	CHEMBL1909192	B	DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)	15	DrugMatrix	Oryctolagus cuniculus		9986	Autocuration	BAO_0000221	10438	CHEMBL4074	SINGLE PROTEIN	P12822	Angiotensin-converting enzyme	Oryctolagus cuniculus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802020	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774688	CHEMBL1909209	B	DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10576	CHEMBL273	SINGLE PROTEIN	P19327	Serotonin 1a (5-HT1a) receptor	Rattus norvegicus	8	Homologous protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801950	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774653	CHEMBL1909174	B	DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	215	CHEMBL2035	SINGLE PROTEIN	P08912	Muscarinic acetylcholine receptor M5	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804107	Ki					Ki				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000192			774730	CHEMBL1909119	B	DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP)	15	DrugMatrix			32644	Autocuration	BAO_0000249	100334	CHEMBL5144	SINGLE PROTEIN	P32241	Vasoactive intestinal polypeptide receptor 1	Homo sapiens	9	Protein			59306	CHEMBL1909046							786	CHEMBL3307768	HT-29		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801895	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774758	CHEMBL1909147	B	DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799803	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774713	CHEMBL1909102	B	DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	22226	CHEMBL612545	UNCHECKED		Unchecked		0	Unassigned			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799801	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774712	CHEMBL1909101	B	DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon))	15	DrugMatrix			32644	Autocuration	BAO_0000249	119	CHEMBL1832	SINGLE PROTEIN	P30988	Calcitonin receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							594	CHEMBL3307606	T47D		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799845	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774751	CHEMBL1909140	B	DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone)	15	DrugMatrix			32644	Autocuration	BAO_0000249	72	CHEMBL217	SINGLE PROTEIN	P14416	Dopamine D2 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							449	CHEMBL3308072	CHO		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799761	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774692	CHEMBL1909213	B	DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX)	15	DrugMatrix			32644	Autocuration	BAO_0000249	114	CHEMBL226	SINGLE PROTEIN	P30542	Adenosine A1 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							449	CHEMBL3308072	CHO		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801913	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774767	CHEMBL1909156	B	DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	127	CHEMBL231	SINGLE PROTEIN	P35367	Histamine H1 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799799	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774711	CHEMBL1909100	B	DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin)	15	DrugMatrix			32644	Autocuration	BAO_0000249	10034	CHEMBL3157	SINGLE PROTEIN	P30411	Bradykinin B2 receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801993	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774675	CHEMBL1909196	B	DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)	15	DrugMatrix	Homo sapiens		9606	Autocuration	BAO_0000221	13000	CHEMBL332	SINGLE PROTEIN	P03956	Matrix metalloproteinase-1	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802009	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774683	CHEMBL1909204	B	DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))	15	DrugMatrix			32644	Autocuration	BAO_0000219	11755	CHEMBL1841	SINGLE PROTEIN	P06241	Tyrosine-protein kinase FYN	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7799777	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774700	CHEMBL1909089	B	DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine)	15	DrugMatrix			32644	Autocuration	BAO_0000249	216	CHEMBL1942	SINGLE PROTEIN	P18089	Alpha-2b adrenergic receptor	Homo sapiens	9	Protein			59306	CHEMBL1909046							485	CHEMBL3307512	CHO-K1		
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802021	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774689	CHEMBL1909210	B	DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol)	15	DrugMatrix	Rattus norvegicus	Wistar	10116	Autocuration	BAO_0000249	10577	CHEMBL3459	SINGLE PROTEIN	P28564	Serotonin 1b (5-HT1b) receptor	Rattus norvegicus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7801959	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774658	CHEMBL1909179	B	DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)	15	DrugMatrix	Escherichia coli		562	Autocuration	BAO_0000357	11039	CHEMBL3464	SINGLE PROTEIN	P29477	Nitric oxide synthase, inducible	Mus musculus	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7802011	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774684	CHEMBL1909205	B	DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))	15	DrugMatrix			32644	Autocuration	BAO_0000219	188	CHEMBL1824	SINGLE PROTEIN	P04626	Receptor protein-tyrosine kinase erbB-2	Homo sapiens	9	Protein			59306	CHEMBL1909046											
CHEMBL468	5028	CHEMBL468	5028	THALIDOMIDE	THALIDOMIDE	258.23	.09	83.55	0	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1	7804104	IC50					IC50				Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)		0	BAO_0000190			774729	CHEMBL1909118	B	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	15	DrugMatrix			32644	Autocuration	BAO_0000219	10979	CHEMBL1868	SINGLE PROTEIN	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	9	Protein			59306	CHEMBL1909046							473	CHEMBL3307501	HUVEC		
